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Human mesenchymal stem cells (hMSCs), also known as mesenchymal stromal 
cells are currently being clinically tested for their therapeutic potential in treating a 
variety of diseases, disorders and injuries. Because hMSCs normally represent just 
a small fraction of human mononuclear cells (MNCs), it is essential that we 
expand them in vitro, before they can be used for research or therapeutic purposes. 
Nowadays hMSCs are still mostly cultivated in different basal culture media that 
are supplemented with human or animal-derived serum (such as FBS).  Because of 
many disadvantages of serum supplementation (e.g. undefined composition, 
inconsistent lot-to-lot performances, high retail price, possible negative effect on 
therapeutic effectiveness of cultivated hMSCs), many researchers are trying to 
develop chemically defined media for serum-free cultivation of hMSCs and 
approaches of serum-reduction processes. In our thesis we have designed 3 
separate gradual serum reduction experiments that were tested on cells, cultivated 
in 3 chemically defined media (Hektor, TurboDoma and SCM-1). These were 
compared in performance to cells,  propagated in control medium (α-MEM + 10 % 
of human serum). Even though we have managed to grow hMSCs in lower serum 
concentrations (at 3% HS for Hektor, TurboDoma; at 1 % HS for SCM-1), the 
serum depletion process had a drastic effect on morphology, viability, growth rates 
and metabolic activty of hMSCs. Moreover none of the 3 investigated chemically 
defined media could support completely serum-free cultivation of hMSCs. 
Although we were not succesful in complete serum elimination, SCM-1 culture 
medium stood out as a potential candidate for further evaluation, which could 
eventually lead to it supporting hMSC growth in completely serum-free 
conditions. 
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Človeške mezenhimske matične celice (hMSC), poznane tudi pod imenom 
mezenhimske stromalne celice, so trenutno vključene v številne klinične študije 
zaradi njihovega terapevtskega potenciala pri zdravljenju različnih bolezni, okvar 
in poškodb. Ker hMSC predstavljajo le majhen delež človeških mononuklearnih 
celic (MNC), jih moramo pred njihovo uporabo v klinične ali raziskovalne 
namene, nujno namnožiti v in vitro pogojih. Dandanes hMSC najpogosteje gojimo 
v bazalnih gojiščih z dodanim serumom, človeškega ali živalskega izvora (npr. 
fetalni goveji serum). Ker pa ima serum kot dodatek gojiščem številne 
pomanjkljivosti (npr. nedefinirana sestava, nekonsistentna učinkovitost od serije 
do serije, visoka cena, morebiten negativen vpliv na terapevtsko učinkovitost 
gojenih hMSC), se številni raziskovalci trudijo razviti pristope zniževanja 
serumske koncentracije v gojiščih in kemijsko definirana gojišča, ki bi omogočala 
brezserumsko gojenje hMSC. Tekom našega magistrskega dela smo razvili 3 
različne pristope postopnega zniževanja serumske koncentracije, ki smo jih 
preiskusili na hMSC, gojenih v 3 kemijsko definiranih gojiščih (Hektor, 
TurboDoma and SCM-1). Učinek zniževanja serumske koncentracije na celice 
smo nato primerjali s celicami, ki so bile ves čas gojene v kontrolnem gojišču s 
konstantnimi pogoji (α-MEM + 10 % človeškega seruma). Čeprav nam je uspelo 
gojiti hMSC pri nižjih koncentracijah seruma (3 % Hektor in TurboDoma, 1 % 
SCM-1), pa je postopek zniževanja serumske koncentracije imel izrazite učinke na 
morfologijo, viabilnost, hitrost rasti in metabolno aktivnost hMSC. Razen tega pa 
nam ni v nobenem izmed 3 kemijsko definiranih gojišč uspelo gojiti hMSC v 
popolnoma brezserumskih pogojih. Čeprav smo bili pri prilagoditvi hMSC na 
brezserumske pogoje neuspešni, pa se je gojišče SFM-1 izkazalo za potencialnega 
kandidata za nadaljnjo proučevanje. Obstaja verjetnost, da bi lahko omenjeno 
gojišče z drugačnimi pogoji zniževanja serumske koncentracije in določenimi 
prilagoditvami v prihodnosti omogočalo popolnoma brezserumsko gojenje hMSC.  
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1 INTRODUCTION 
 
Mesenchymal stem cells (MSC) were first characterized by Friedenstein et al. (1970), as 
clonal, plastic-adherent cells, and serving as a source of osteoblastic, adipogenic and 
chondrogenic cell lines (Chen et al., 2014). MSCs were first found in bone marrow in 1970 
(Friedenstein et al., 1970), but have been later also isolated from other tissues including 
peripheral blood, umbilical cord blood (UCB), placenta and adipose tissues (AT) (Kogler 
et al., 2004; Lee et al., 2004). Since their first identification in 1970s, a lot of focus has 
been placed on the use of MSCs for cell-based therapies and more recently also for the use 
of MSCs for paracrine support and immune modulation, including the prevention of graft-
versus-host disease (GvHD). 
As the population of MSCs in foetal or especially adult tissue is always low compared to 
other nucleated cells, it is essential that we efficiently expand them in vitro for later 
research or clinical application purposes. Historically, MSCs culture medium has 
constituted a basal culture medium (Dulbecco’s Modified Eagle’s Medium (DMEM) or 
Minimum Essential Medium alpha (α-MEM)), which was supplemented with foetal bovine 
serum (FBS) or human serum (HS), with or without additional growth factors (e.g. basic 
fibroblast growth factor (FGF)). Although these traditional formulations provide robust 
undifferentiated MSC expansion, the ill-defined composition of serum, high retail prices, 
unethical manufacturing processes (FBS), inconsistent lot-to-lot performance and 
contamination risks have pushed academic groups and industry to develop new 
chemically-defined media (Chase et al., 2010). This media should enable experiments in 
serum-free conditions, which will reduce variability in qualitative and quantitative culture 
medium composition, reduce risk of microbial contamination (mycoplasma, viruses, 
prions), ease the isolation of cell culture products (down-stream processing) and reduce or 
completely avoid suffering of animal foetuses and adult animals (FBS) (Brunner et al., 
2010). 
Although there are many serum-free media on the market today, it is still a golden standard 
to supplement stem cell and cell culture media with serum. In this thesis, we analysed key 
biological characteristics of human umbilical cord-MSCs (ucMSCs) during a prolonged in 
vitro cultivation with a gradual serum reduction approach. Biological features included 
possible morphological changes, viability, growth curve characteristics, senescence and 
metabolic activity. 
 
1.1 RESEARCH OBJECTIVES 
 
In our experiment we tried to adapt primary human mesenchymal stem cells (hMSC), 
isolated from umbilical cord, to cultivation in serum-free media. Our plan was to gradually 
reduce serum concentration in our media and achieve cultivation in serum-free conditions. 
Serum reduction process was performed in 3 different chemically defined media, while 1 
batch of cells was passaged in control medium (α-MEM) with 10 % of HS for later 
comparison in performance. During serum reduction process we monitored the cells for 
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any morphological changes, which could occur as a consequence of lowering serum 
concentration, observed growth parameters, metabolic activity and viability of our cells 
and performed analyses to detect senescence in cells, which could occur as a result of a 
high number of passages. Three different reduction approaches were attempted to reach 
serum-free cultivation. In the so called slow reduction approach we lowered serum 
concentration once per week, while leaving cells at the same serum concentration for 1 
more passage before reducing serum concentration again. That gave hMSCs more time to 
adapt to a lower serum concentration. In our fast reduction process we lowered serum 
concentration twice per week, which meant that serum concentration was reduced every 
passage. The third approach was designed in a way that cells were only passaged, when 
they reached the desired confluence (preferably higher than 60 %) and serum concentration 
was lowered at the same time, during each cell splitting. The objective of our experiment 
was to determine, if our media could be used for stem cell cultivation without any serum 
content and which one of the 3 was the most suitable for MSCs, isolated from umbilical 
cord blood. 
 
1.2 HYPOTHESIS 
 
In the beginning of our experimental work we had established the following hypothesis: 
• It is possible to wean primary mesenchymal stem cells from serum-supplemented 
medium and cultivate them in serum-free medium. 
• If the correct approach is used to lower the serum-concentration, cells will adapt to 
lower serum concentration and eventually grow without any serum 
supplementation. 
• If the chemically defined media we used are designed correctly, they should enable 
our MSCs to survive serum reduction approach and later proliferate in serum-free 
conditions. 
• Our serum reduction process and chemically defined media will enable our cells to 
adapt to gradual lower serum concentration without imposing stress and 
morphological changes, while maintaining cell growth, viability and metabolic 
activity. 
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2 LITERATURE REVIEW 
2.1 MESENCHYMAL STEM CELLS 
 
MSCs are one of the somatic stem cell populations that possess asymmetric self-renewal 
potential and ability to differentiate into mesodermal lineage upon induction with 
appropriate differentiation-inducing factors (Sato et al., 2015). MSCs or MSC-like cells 
can be expanded from numerous compartments, including human bone marrow, skeletal 
muscles, adipose tissue, umbilical cord, synovium, dental pulp, amniotic fluid, human 
embryonic stem cells, and numerous other sources (Figure 1) (Phinney and Prockop, 2007; 
Lian et al., 2007). Human MSCs (hMSCs) isolated and expanded in classical FBS-
containing media are mostly spindle-shaped (or fusiform) and cuboidal fibroblast-like cells 
(Jung et al., 2012). Sekiya et al. (2002) also observed that hMSCs go through a time-
dependent morphological conversion from thin, spindle-shaped cells (which are considered 
to be stem cells or early progenitors) to wider (larger), spindle-shaped cells (in appearance 
more similar to mature cells) when cells are plated at 1 to 1000 cells/cm2. 
 
 
Figure 1: Sources of MSCs. MSCs can be derived from many different infant or adult tissues (Phuc Pham, 
2011). 
Slika 1: Viri mezenhimskih matičnih celic (MMC). MMC lahko izoliramo iz številnih različnih otroških ali 
odraslih tkiv (Phuc Pham, 2011). 
 
Because the MSCs from different sources are distinct in their characteristics (e.g. 
proliferation rate, surface antigen expression, differentiation potency) and functional 
capacity (Shetty et al., 2010) the International Society of Cellular Therapy (ISCT) has 
established the minimum criteria for characterization of MSCs. Included are adhesion 
ability to plastic vessel, expression of cell surface antigens, such as CD73, CD90 and 
CD105, and absence of cell surface antigens, CD14, CD34, CD45 and HLA-DR. MSCs 
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also have to maintain an ability of in vitro differentiation into osteoblast, adipocyte and 
chondrocyte cell lines (Dominici et al., 2006). 
As a consequence of their great potential as therapeutic agents in regenerative medicine, 
MSCs have become a subject of many research projects. Clinical trials are underway for 
using MSC therapies for a variety of disorders that include Crohn’s disease, multiple 
sclerosis, graft - versus - host disease, type 1 diabetes, bone fractures and cartilage defects, 
just to name a few (Figure 2).  
 
Figure 2: Number of common diseases registered for MSCs based therapy (Ullah et al., 2015) 
Slika 2: Število znanih obolenj, registriranih za terapije z MMC (Ullah in sod., 2015) 
 
The number of MSCs in any tissue where they are found is very small. Kern et al. (2006) 
reported in their study that hMSCs accounted for 557 (stromal vascular fraction of adipose 
tissue) and 83 (bone marrow) clones per 1 ✕ 106 mononuclear cells (MNCs), while 
Bieback et al. (2004) describe even smaller numbers, when dealing with MSCs in 
umbilical cord blood (0 to 2.3 clones per 1 ✕ 108 MNCs) (Table 1).  That is why it is 
absolutely necessary to expand MSCs in vitro for any possible research or clinical use. For 
in vitro expansion of MSCs we need a culture medium, which is in most cases comprised 
of basal medium like Dulbecco’s Modified Eagle’s Medium (DMEM), α-minimum 
essential medium (α-MEM) or Ham’s F12. In addition of basal medium, culture media for 
MSCs normally also contain serum of animal or human origin and growth factors (Chen et 
al., 2014).  
Table 1: Isolation frequency of colony forming units (CFU-F) from different tissues per 1 ✕ 106 of MNC 
(Kern et al., 2006) 
Preglednica 1: Pogostost fibroblastov, ki tvorijo kolonije (CFU-F), izoliranih iz različnih tkiv na 1 ✕ 106 
mononuklearnih celic (MNC) (Kern in sod., 2006) 
Tissue CFU-Fs per 1 ✕ 106 MNC 
Stromal vascular fraction of adipose tissue 557  
Bone marrow 83  
Umbilical cord blood 0,00 to 0.023 
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2.2 SERUM’S ROLE IN STEM CELL CULTIVATION 
 
Serum is the clear portion of blood obtained after removing cells, platelets and clotting 
factors (Venes and Taber, 2009). It contains amino acids, proteins, growth factors, 
hormones, vitamins, inorganic substances, nutrients and metabolites (Freshney, 2010: 110) 
(Table 2) and is often used in mammalian cell culture as a supplement to culture media 
(added in the range of 5-15 % (v/v)) to promote and sustain cell growth as well as provide 
buffering and protection to cells. 
 
Table 2: Constituents of serum (Freshney, 2010: 110) 
Preglednica 2: Sestavine seruma (Freshney, 2010: 110) 
 
Constituent 
Range of 
concentrationa 
  
Constituent 
Range of 
concentrationa 
Proteins and polypeptides 
Albumin 
Fetuinb 
Fibronectin 
Globulins 
Protease Inhibitors: 
α1-antitrypsin 
α2-macroglobulin 
Transferrin 
40-80 mg/mL  Polyamines: 0.1-1.0 µM 
20-50 mg/mL  Putrescine, 
Spermidine 
 
10-20 mg/mL    
1.0-10 µg/mL  Urea 170-300 µg/mL 
1.0-15 mg/mL    
0.5-2.5 mg/mL  Inorganics 0.14-0.16 M 
  Calcium 4.0-7.0 mM 
  Chlorides 100 µM 
2.0-4.0 mg/mL  Iron 10-50 µM 
   Potassium 5.0-15 mM 
Growth factors:   Phosphate 2.0-5.0 mM 
EGF, PDGF, IGF1 and  1.0-100 ng/mL  Selenium 0.01 µM 
2, FGF, IL-1, IL-6   Sodium 135-155 mM 
   Zinc 0.1-1.0 µM 
Amino acids 0.01-1.0 µM    
   Hormones 0.1-200 nM 
Lipids 2.0-10 mg/mL  Hydrocortisone 10-200 nM 
Cholesterol 10 µM  Insulin 1.0-100 ng/mL 
Fatty acids 0.1-1.0 µM  Triiodothyronine 20 nM 
Linoleic acids 0.01-0.1 µM  Thyroxine 100 nM 
Phospholipids 0.7-3.0 mg/mL    
   Vitamins 0.01-10 µg/mL 
Carbohydrates 1.0-2.0 mg/mL  Vitamin A 10-100 ng/mL 
Glucose 0.6-1.2 mg/mL  Folate  
Hexosaminec 0.6-1.2 mg/mL    
Lactic acidd 0.5-2.0 mg/mL    
Pyruvic acid 2.0-10 µg/mL    
aThe range of concentrations is approximate and is intended to convey only the order of magnitude 
bIn foetal serum only 
cHighest in human serum 
dHighest in foetal serum 
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2.2.1 Advantages and disadvantages of serum-supplemented media 
 
Serum-supplemented media have been and still are used in stem cell cultivation for a 
reason. Arora (2013) listed following advantages of serum in culture media: 
• Serum supplies cultured cells with basic nutrients (both in solution as well as bound 
to the proteins). 
• It provides several growth factors and hormones involved in growth promotion and 
specialized cell function. 
• Serum contains several binding proteins like transferrin and albumin, which can 
transport other molecules into the cell (e.g. albumin can carry lipids, vitamins, 
hormones, etc. into cells). 
• It supplies proteins, like fibronectin, that help cells attach to the surface of culture 
vessels. 
• Serum also includes protease inhibitors, which protect cells from proteolysis. 
• It provides minerals, like Na+, K+, Zn2+, Fe2+, etc. 
• It increases medium viscosity and consequently protects cells from shear stress 
during agitation of suspension cultures or during cell splits. 
• It acts like a buffer. 
• Because of serum’s complex composition it can be used as a supplement with basal 
media for almost any cell type cultivation. 
Serum’s complex composition is beneficial and harmful at the same time. It contains both 
growth factors and inhibitors. FBS-based media remain a common standard in generating 
hMSCs for basic research and clinical studies as well, however the use of FBS is not 
desirable, because of several safety and other concerns. Potential problems associated with 
the ill-defined FBS and other animal-derived supplements can be found in table 3. 
Table 3: Advantages and disadvantages of using serum in culture media (Arora, 2013; Jung et al., 2012) 
Preglednica 3: Prednosti in slabosti uporabe seruma v gojiščih (Arora, 2013; Jung in sod., 2012) 
Advantages of serum in media Disadvantages of serum in media 
Growth factors and hormones that stimulate cell 
growth and functions 
Lack of uniformity in the composition of serum 
(problems with standardization, due to batch-to-
batch variations 
Helps in attachment of the cells Risk of contamination 
Acts as a spreading factor High content of xenogeneic proteins 
Acts as a buffering agent which helps in maintaining 
the pH of culture media 
Presence of growth inhibitors, cytotoxic substances 
and/or differentiation agents 
Functions as a binding protein Requirement of a set of strict quality controls to 
minimize the risk of contamination 
Minimizes mechanical damages or damages causes 
by viscosity 
Interference of unidentified factors on the effect of 
hormones, growth factors, or other additives under 
investigation 
 Limited availability and high cost 
 Ethical issues 
 Downstream processing 
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If we consider advantages and disadvantages of serum supplementation, we can conclude 
that despite strict selection and testing for safety and growth-promoting capacity, the use of 
FBS represents a major obstacle for the wide implementation of hMSC-related therapies. 
Although relatively safer than FBS for human therapeutic application, the use of human-
sourced supplements is still a matter of debate. Even if we use HS, plasma, platelet-
derivatives and cord blood serum, we still come across some similar problems as with 
animal-derived supplements. There is a possibility that the allogeneic human growth 
supplements are contaminated with human pathogens, which are not detected with routine 
screening of blood donors (Jung et al., 2012). Furthermore, these blood derivatives are also 
poorly defined and suffer from similar consequent problems as FBS, like batch-to-batch 
variation, therefore their ability to maintain hMSC growth and therapeutic potential could 
vary immensely. Because of great variability between different batches, implementation of 
clinical-scale production of hMSCs could be more difficult to implement (Jung et al., 
2012). The biggest problem is that with big variations in serum supplements, it would be 
very hard to obtain cells retaining desired qualities in a consistent and predictable manner, 
which is very important, when you are trying to minimize treatment failures (Jung et al., 
2012). That is why a lot of scientists agree, that the best solution in a long run is a design 
of chemically defined serum-free media, with which we would be able to eliminate all the 
problems, connected with serum supplementation. 
 
2.3 DEVELOPMENT OF CHEMICALLY-DEFINED SERUM-FREE MEDIA 
 
Chemically defined serum-free media development or optimization for a specific cell type 
can be a very challenging process, because multiple variables, affecting the maintenance, 
growth, and characteristics of cells are interconnected (Jung et al., 2012). Designing 
serum-free media for adherent cells like hMSCs is even more difficult, because compared 
to cells, grown in suspension culture, we also need to understand the interaction of 
adherent cells with the substrate on which they attach and spread prior to growth. Medium 
development studies should consist of rational approaches: 
• To select suitable factors (e.g. basal medium formulations and attachment/growth 
proteins) 
• To screen them in a stepwise, systematic manner for their impact on cell 
characteristics and growth. 
There are a few general approaches to serum-free media development for a specific cell 
line or primary culture and 3 of them are listed below. 
 
2.3.1 Ham’s approach 
 
In first one we take a familiar recipe for a related cell type, which can be supplemented 
with 10 – 20 % of dialyzed serum, and then alter the components one by one or in groups, 
against a variety of serum concentrations (as well as 0%) (Freshney, 2010: 124). Clonal 
growth analyses will then demonstrate any frugal outcomes of a possible serum 
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replacement (i.e. in the presence of the replacement, we will need less serum to acquire the 
same clonal growth). We can then determine the ideal concentration of the compound at 
the lowest serum supplementation, which would still allow clonal growth.  This approach 
was embraced by Ham (1984) and will basically provide optimal conditions. When a group 
of compounds demonstrate efficacy in reducing serum supplementation, we can identify 
the active ingredient by the systematic omission of a single component and then optimize 
the concentrations of the essential components (Ham, 1984). Unfortunately the above-
mentioned method is a very time-consuming and laborious process. It may take us at least 
3 years to develop a new medium formulation for a new cell type (Freshney, 2010: 129). 
 
2.3.2 Sato’s Approach 
 
Compared to Ham’s approach, which is analytical in nature, Sato et al. (1980) developed a 
synthetic method for the replacement of serum in culture media. In this approach the 
researchers have supplemented well known media such as RPMI 1640 (Carney et al, 1981) 
or combination of media such as DMEM with Ham’s F12 (Barnes and Sato, 1980) and 
manipulated only a shorter list of substances. Once again, the ideal concentrations were 
determined at a limiting serum supplementation. Some of the most regularly analysed 
substances are transferrin, selenium, albumin, estrogen, insulin, hydrocortisone, 
triiodothyronine ethanolamine, phosphoethanolamine, growth factors (epidermal growth 
factor (EGF), fibroblast growth factor (FGF), platelet-derived growth factor (PDGF), 
endothelial growth supplement, etc.), prostaglandins (prostaglandin E1, prostaglandin F2α), 
and any other substances that may have special importance (Freshney, 2010: 129). Barnes 
and Sato (1980) identified various key essential supplements for many cell types, such as 
hormones, binding proteins, lipids, trace elements and attachment factors, required for 
addition to basal medium. Most importantly, they have discovered that transferrin, insulin 
and selenium are essential for the growth of most cells, whereas EGF and hydrocortisones 
have to be added for certain types of cells. With this approach Barnes and Sato (1980) 
managed to replace serum with specific supplements for a number of different cell types, 
without significantly changing the basal medium. Even though this approach was quite 
effective, it still takes a lot of time and work (Jung et al., 2010). 
 
2.3.3 Top-down and Bottom-up approaches 
 
Top-down and bottom-up approaches can also be used for the formulation of new serum-
free medium formulation and are considered more practical (Butler and Burgener, 2005). 
In Top-down approach we make use of an existing medium formulation, which is already 
used for a similar type of cells, and then identify stimulatory constituents in the presence of 
serum for the growth of investigated cells (Jung et al., 2010). The process continues, while 
the serum content is slowly reduced. This approach was developed through a hypothesis 
that a cell type that belongs to a group of cells with similar characteristics, often need the 
same or comparable mixture of growth factors for growth. 
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In the Bottom-Up method we select an appropriate basal medium (generally a medium that 
is used for the proliferation of a related cell type) and then screen selected exogenous 
factors for their influence on the stimulation of growth (Jung et al., 2010). Because the 
medium is only supplemented with active components, which are required for an adequate 
growth of our cell type, the final composition will embody a compact and easily adaptable 
medium. This method is considered to be quite labour-intensive and time-consuming, and 
it also has to be taken into account that screening of factors is executed in serum-free 
conditions. That is why, it is necessary that critical functions of serum, required to see the 
effects of our screened factors, are carefully evaluated and satisfied by different means 
(e.g., treatment of culture surface, well-controlled physiochemical parameters, 
trypsinization and passage protocols) (Jung et al., 2010). Serum-free basal medium does 
not normally provide such functions. 
 
2.3.4 Serum-free design in practice 
 
Because none of the before-mentioned approaches is perfect and without its faults, it is 
very important for each researcher to know and understand disadvantages and advantages 
of any one of them and then use the best qualities of them all. When Jung et al. (2012) 
were developing a new hMSC serum-free medium, they chose different medium 
ingredients, such as basal medium, binding proteins, extra nutrients, hormones, buffering 
agents, vitamins and growth and attachment factors, built on their understanding of the 
requirements of cell culture (including the role of serum ingredients). Chosen factors were 
then investigated in a consecutive manner, using the best characteristics of each method, 
described earlier. In doing so Jung and his colleagues determined chronological influence 
on proliferation, attachment and isolation of hMSCs (Figure 3). 
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Figure 3: Outline representing a procedure for the development of a defined serum-free medium for hMSCs. 
(a) Ill-defined serum was substituted with chosen well-defined supplements, which included a selection of 
medium components, such as basal media, additional nutrients (e.g. lipids and vitamins), binding proteins, 
hormones, physiochemical reagents (e.g. buffer), growth factors and attachment factors. (b) Sequential 
strategy was planned for efficient screening of chosen basal media and medium supplements to develop a 
defined serum-free condition that supports the isolation and proliferation of hMSCs (Jung et al., 2010). 
Slika 3: Shema prikazuje proces razvoja definiranega brezserumskega gojišča za človeške MMC. a) Slabo 
definirani serum je bil zamenjan z izbranimi dobro definiranimi dodatki, ki so vključevali izbor komponent 
gojišč, kot so bazalno gojišče, dodatna hranila (npr. lipidi in vitamini), vezavni proteini, hormoni, 
fiziokemični reagenti (npr. pufer), rastni dejavniki in vezavni dejavniki. b) Sekvenčna strategija je bila 
načrtovana za bolj učinkovito presejanje bazalnih gojišč in gojitvenih dodatkov, kar bi nam omogočilo 
vzpostavitev definiranih brezserumskih pogojev, ki bi podpirali izolacijo in proliferacijo človeških MMC 
(Jung in sod., 2010). 
 
2.4 ADAPTATION OF MESENCHYMAL STEM CELS TO SERUM-FREE MEDIUM 
 
There are many different approaches to adapting mammalian cells to serum-free 
cultivation. When dealing with cell cultures, gradual weaning processes are normally used, 
that involve progressive adaptation to lower serum concentrations until serum-free 
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conditions are reached (van der Valk et al., 2010). Cultures, planned for the adaptation 
should be in the logarithmic phase of growth and should display viability, higher than 90 
%. Van der Valk et al. (2010) also state, that because of the adaptation process, an 
unwanted selection of a change in the population of cells can occur, by indirectly selecting 
cells capable of growth in serum-free media. Hence it is essential to monitor cellular 
morphology and function during the weaning process and check the performance of 
cultures. A few of adaption protocols are presented below (Figure 4). 
 
 
Figure 4: Adaptation of cultures to serum-free medium. A comparison of the most common adaptation 
protocols (FBS: foetal bovine serum and SFM: serum-free medium) (van der Valk et al., 2010) 
Slika 4: Prilagoditev celičnih kultur na brezserumska gojišča. Primerjava najbolj običajnih adaptacijskih 
protokolov (FBS: fetalni goveji serum; SFM: brezserumsko gojišče) (Van der Valk in sod., 2010) 
 
2.4.1 Reduction of serum content 
 
In this approach serum content is reduced in every passage, until we reach 0.1 %. We start 
with propagation in normal medium with 10 % of serum, then move the cells to serum-free 
medium with 5 % of serum, after which we subcultivate cells in 1 % serum, etc. Serum-
free medium can be supplemented with hormones. 
 
2.4.2 Sequential adaptation 
 
Quite related to the first approach, cells in sequential adaptation method are split into 
combinations of serum-supplemented and serum-free media, until complete serum-free 
cultivation is achieved. If the last step, when cells are transferred from 75 % to 100 % 
serum-free medium, imposes too much stress on cells, it is suggested to add another step 
with 10 % of serum-supplemented and 90 % serum-free medium for 2-3 passages, before 
moving to a completely serum-free conditions (van der Valk et al., 2010). 
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2.4.3 Adaptation with conditioned medium 
 
This method keeps to similar steps than Sequential adaptation approach, but uses reducing 
combinations of conditioned media from past passages. 
 
2.4.4 Inside adaptation 
 
In this method freshly harvested cells are weaned in serum-free medium, and then cultures 
are propagated to confluence. The confluent monolayer is then split into serum-free 
medium. With this approach it is recommended to passage cells in 2 to 4x higher cell 
density. 
 
2.4.5 Approaches, preferred for hMSCs 
 
There have been many attempts by different research groups to develop serum-free media 
for human or animal MSC growth, but many of them achieved inadequate performance 
(Lennon et al., 1995; Liu et al., 2007; Marshak and Holecek, 1999; Parker et al., 2007). 
Media compositions, designed in the referred studies only supported cell expansion for 
single-passage cultures or at slow rates through multiple passages. Jung et al. (Jung et al., 
2012) propose, that this could be a consequence of serum supplementation in initial 
isolation/expansion phases. Serum-derived contaminants could be transferred with the cells 
when they are being adapted to serum-free conditions after exposure to serum, hence the 
serum supplementation in any stage of cell handling could ultimately limit their therapeutic 
use (Jung et al. 2012). That is why many studies agree, that the best approach is to exclude 
the use of serum even in the isolation steps (Sato et al., 2015; Chen et al., 2014). Those 
studies also demonstrated best performance of serum-free media. In fact in studies, where 
serum-free media were used from the very beginning (including isolation), MSCs even 
outperformed MSCs in serum-supplemented media in cell growth, viability at isolation and 
potential for bone repair (Sato et al., 2015; Al-Saqi et al., 2014), and had a comparable 
biological stability to cells, cultured in SSM.  
If our source material was already isolated and cryopreserved, before we start with our 
experiment (as was the case in our experiment), we can decide to move cells straight into 
serum-free conditions (inside adaptation approach) or gradually reduce serum 
concentration and give the cells time to adjust to lower serum concentrations. We decided 
to adopt the latter. 
 
2.5 CELL CULTURE ASPECTS IN SERUM-FREE CONDITIONS 
 
Generally the cells in serum-free media and during the adaptation process are more 
sensitive to any kind of extremes, such as low or high temperature, pH variations, and 
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changes in osmolality and shear force (Jung et al., 2012). We also have to be more careful 
with enzyme treatment. They should be handled with great care to minimize cell damage 
that could immensely lower the viability of our cell population. The following points 
should be considered, before starting the adaptation procedure or serum-free cultivation. 
 
2.5.1 Antibiotics 
 
It is highly recommended to avoid using antibiotics in serum-free cultivation. Because 
there are no serum proteins to bind antibiotic, the levels of antibiotic in cell culture 
medium may be toxic to the cells. If they are added to the culture medium, they should be 
used in concentrations that are 5 to 10 times lower than in serum-supplemented media 
(ThermoFisher Scientific, 2015). 
 
2.5.2 Buffer System of Media 
 
Because serum also plays a buffering role in cell culture media (modulates pH), it is 
recommended to add a chemical buffer, such as HEPES, in addition to bicarbonate-CO2 
system, in order to increase the buffering capacity of the medium (Jung et al., 2012). 
HEPES can be added to concentrations, higher than 15 mM without becoming toxic to the 
cells, but it may be necessary to adjust osmolality of the medium accordingly (Barnes and 
Sato, 1980). 
 
2.5.3 Lack of detoxifying Substances and Protease inhibitors 
 
Because there are no serum proteins to bind and neutralize toxic contaminants, medium’s 
protective and detoxifying activity is compromised. That is why, it is even more essential, 
that water, reagents and culture techniques are selected with great care. The addition of 
serum to cells, exposed to trypsin, also neutralizes any residual proteolytic activity (Jung et 
al., 2012). In absence of serum, we can use protease inhibitors to the same effect, or choose 
a different dissociation solution that allows the dislodging without the use of enzymes (e.g. 
Sigma non-enzymatic dissociation solution). 
 
2.5.4 Higher density 
 
Before we start with the adaptation, we should check that cells are in mid-logarithmic 
phase of growth and are highly viable (>90 %). Cells should also be seeded at a higher 
concentration, so that the appropriate numbers of cells are grown to perform further 
passages.  
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2.5.5 Clumping and morphology 
 
One of the common problems that occur during adaptation to SFM is cell clumping. 
Clumping normally becomes apparent during the dissociation step. Longer incubation time 
and gentle trituration is proposed to break down clumps and obtain separate single cells. 
Small changes in cellular morphology are not uncommon during and after adaptation to 
SFM, but as long as doubling times and viability stay in normal values, it should not be a 
reason for concern. It is recommended to have an adequate amount of frozen cell stock 
before we start with the adaptation, so we can repeat the procedure, if something goes 
wrong. 
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3 MATERIALS AND METHODS 
3.1 COURSE OF THE EXPERIMENTS 
 
We have lined out the course of all 3 different gradual serum reduction approaches in 
tables 4, 5 and 6. 
 
Table 4: Course of the slow reduction approach through passages 
Preglednica 4: Potek dela pri počasnem zmanjševanju serumske koncentracije v različnih pasažah 
Passage Assessments, performed 
during each passage 
Main procedures Weekly assessments 
P1  Thawing of the hMSC  
P2 (10% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Transfer of hMSCs to 4 different 
media 
Seeding of cells for 
MTT viability assay 
P3 (10% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting  
P4 (5% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction Seeding of cells for 
MTT viability assay 
P5 (5% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting  
P6 (3% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction Seeding of cells for 
MTT viability assay 
2%, 1% 0.5%, 
0,3 % 
P7-P15 
. 
. 
. 
. 
. 
. 
. 
. 
. 
P16 (0.1% 
HS) 
Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction Seeding of cells for 
MTT viability assay 
P17 (0.1% 
HS) 
Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting  
P18 (0.0% 
HS) 
Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction Seeding of cells for 
MTT viability assay 
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Table 5: Course of work for fast reduction experiment 
Preglednica 5: Potek dela pri hitrem zmanjševanju serumske koncentracije 
Passage Assessments, performed 
during each passage 
Main procedures Weekly assessments 
P1  Thawing of the hMSC  
P2 (10% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Transfer of hMSCs to 4 different 
media 
Seeding of cells for 
MTT viability assay 
P3 (5% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction  
P4 (3% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction Seeding of cells for 
MTT viability assay 
2%, 1% 0.5%, 
0,3 % 
P7-P15 
. 
. 
. 
. 
. 
. 
. 
. 
. 
P9 (0.1% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction  
P10 (0.0% 
HS) 
Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction Seeding of cells for 
MTT viability assay 
 
 
Table 6: Course of work for adjusted reduction experiment 
Preglednica 6: Potek dela pri prilagojenem zmanjševanju serumske koncentracije  
Passage Assessments, performed 
during each passage 
Main procedures Weekly assessments 
P1  Thawing of the hMSC  
P2 (10% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Transfer of hMSCs to 4 different 
media 
Seeding of cells for 
MTT viability assay 
P3 (5% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction 
(only at confluence >60 %) 
 
P4 (3% HS) Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction 
(only at confluence >60 %) 
Seeding of cells for 
MTT viability assay 
2%, 1% 0.5%, 
0,3 % 
P7-P15 
. 
. 
. 
. 
. 
. 
. 
. 
. 
P9-14 (0.1% 
HS) 
Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction 
(only at confluence >60 %) 
 
P10-15 (0.0% 
HS) 
Cell counting, trypan 
blue staining, 
morphology assessment 
Cell splitting + serum reduction 
(only at confluence >60 %) 
Seeding of cells for 
MTT viability assay 
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3.2 MATERIALS 
 
3.2.1 Chemicals 
 
In our work we used the following chemicals: MTT powder (Sigma Aldrich, USA), PBS 
(Life Technologies, USA), Gentamyicine (Biozym, Germany), human serum (Blood Bank 
Linz, Red Cross Austria, Austria), Accutase (PAA Laboratories, Austria), Cell 
Dissociation Solution Non-enzymatic 1x (Sigma Aldrich, USA), N,N-Dimethylformamide 
(Sigma Aldrich, USA), glycerol (Sigma Aldrich, USA), Trypan Blue solution (Life 
Technologies, USA). 1% GlutaMAX™ medium supplement (Life Technologies, USA), 
ethanol (Carl Roth Gmbh & Co. KG, Germany), SDS (Sigma Aldrich Gmbh, Germany) 
 
3.2.2 Media 
 
In our research we used the following media: 
• α-MEM medium: 10 % (v/v) HS 
• TurboDoma® medium: 10 % (v/v), 5 %, 3 %, 2 %, 1 %, 0.5 %, 0.3 %, 0.1 % HS, 
1% GlutaMAX™ 
• Hektor® medium: 10 % (v/v), 5 %, 3 %, 2 %, 1%, 0.5 %, 0.3 %, 0.1 % HS, 1% 
GlutaMAX™ 
• Stemcell Cell Medium 1 (SCM-1): 10 % (v/v), 5 %, 3 %, 2 %, 1 %, 0.5 %, 0.3 %, 
0.1 % HS, 1% GlutaMAX™ 
 
The company called Cell Culture Technologies supplied all 3 chemically defined media. 
 Stem Cell Medium 1 (SCM-1) was created as a basal minimal medium for the cultivation 
of stem cells, and turned out to support proliferation of immortalized hMSC_TERT cells 
with no supplements as demonstrated by the Technische Hochschule Mittelhessen in 
Giessen, Germany. Such minimal medium exclusively consists of small molecules and 
contains no growth factors, no proteins and no peptides. Currently, SCM-1 is used to grow 
stem cells of various origins when properly supplemented with selected growth factors. 
The medium is buffered with HEPES. 
The TurboDoma® media were developed in the 90's to grow hybridomas. The TP-6 
version is a production medium currently used by life science companies to produce 
monoclonal antibodies (mAb) for diagnostic purposes. Compared to SCM-1, the TP-6 
medium contains more nutrients to ensure high cell density and productivity. 
Hektor® S medium was developed for the transient transfection of 293T and 293EBNA 
cells. Such medium was developed in collaboration with Zisch et al. (2003). The same 
medium was reported to sustain serum-free proliferation of several kidney-derived 
mammalian cell lines. The nutrient strength of the Hektor S medium is comparable to 
SCM-1. 
Jan V. Serum reduction approaches in mesenchymal stem cell media. 
   M. Sc. Thesis. Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Biotechnology, 2015 18 
3.2.3 Buffers, solutions and reagents 
 
Table 7: Solutions and reagents for Senescence beta-Galactosidase Cell Staining Protocol 
Preglednica 7: Raztopine in reagent za β-galaktozidazni test celične senescence 
Solution or reagent Composition of the solution or reagent 
10X Fixative Solution 20% formaldehyde, 2% glutaraldehyde in 10X PBS 
10X Staining Solution 400 mM citric acid/sodium phosphate (pH 6.0), 1.5 M NaCl, 20 mM 
MgCl2 
X-Gal 5-bromo-4-chloro-3-indolyl-βD-galactopyranoside powder 
100X Staining Solution 
Supplement A 
500 mM potassium ferrocyanide 
Staining Solution Supplement B 500 mM potassium ferricyanide 
 
3.2.4 Cell type 
 
We used umbilical cord-derived mesenchymal stem cells from a single donor, labelled 
ucMSC130613 for all our experiments. Cells were isolated from umbilical cord Wharton’s 
jelly. Label describes the type and isolation date of cells and is used for group’s Liquid 
Nitrogen Log. General information of the cells is as follows: 
• Cells were isolated on the 13th of June, 2013 in-house from umbilical cord tissue 
according to an SOP routinely used in the research group. 
• Biological material was obtained from a blood bank of Linz Red Cross under valid 
ethical approval. 
• Cells grow plastic adherent and present important MSC surface markers (analysis 
based on commercial flow cytometry kit (Miltenyi). 
• Cells have been tested for differentiation potential towards osteogenic, adipogenic 
and chondrogenic lineage using commercial media (Miltenyi). Differentiation was 
verified by staining with Calcein, Alizarin Red, von Kossa, Oil Red O, Alcian 
Blue. 
• Cells have normal human female karyotype 46, XX (analysis performed by prof. 
Neesen’s group at the Institute of Medical Genetics at Medical University of Wien. 
• Under standard cultivation conditions, the cells had an average doubling time of 35 
h in the first 10 doublings (37 °C/5 % CO2 in α-MEM medium with 10 % of HS). 
• The cells can be proliferated (at standard conditions) for more than 20 passages 
before they start to become senescent around passage 24-26. 
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3.2.5 Laboratory equipment 
 
The following equipment was used during our practical work: Neubauer counting chamber 
(Brand, Germany), centrifuge for conical tubes (Eppendorf AG, Germany), ultra-pure 
water system Arium 611 (Sartorius AG, Germany), microscope Leica DMIL LED (Leica 
Camera AG, Germany), incubator Heracell 150i (Thermo Scientific Gmbh, Germany), 
Thermo Scientific Multiskan™ FC Microplate photometer (Thermo Scientific Gmbh, 
Germany), suction pump biovac 106 ILMVAC (ILMVAC Gmbh, Germany), clean bench 
MSC-Advantage (Thermo Scientific Gmbh, Germany), water bath (GFL Gmbh, 
Germany), refrigerator -80 °C Hera freeze basic (Thermo Scientific Gmbh, Germany), 
cryo tank -165 °C Cryotherm Biosafe MD (Cryotherm Gmbh & Co. KG, Germany), 
Autoclave Varioklav (Thermo Scientific, Germany), Scale (Sartorius AG, Germany), 
Vortex (Aigner Unilab Gesmbh, Austria), cam Leica ICC50 HD (Leica Camera AG, 
Germany), refrigerator HITECH ARTIS (AEG), magnetic stirrer MSH BASIC (IKA 
Werke Gmbh & Co KG, Germany), pipetting aid Pipetboy acu 2 (INTEGRA Biosciences 
AG, Switzerland), cell culture flasks T25, T75, T175 (Sarstedt AG & Co., Germany), cell 
culture plates 6-, 12-, 24-. 96-wells (Sarstedt AG & Co., Germany), 15 and 50 ml conical 
tubes (Corning Inc., USA). 
 
3.3 METHODS 
3.3.1 Isolation of MSCs from umbilical cord 
 
Even though other researchers in the group did the isolation of MSCs beforehand, we are 
adding a short description of the method, which was described by Moretti et al. (2010). 
Cells were isolated from umbilical cord’s Wharton’s jelly, which is a gelatinous connective 
tissue of umbilical cord that represent a rich source of multipotent stem cells. 
In the days before the isolation, the appropriate amount of cell culture medium was 
prepared and the instruments were steam sterilized. On the day of isolation sterile and 
syringe filtered (0.2 µm pore size) culture medium was prewarmed. Umbilical cord was 
removed from buffered transport medium and then perforated via tweezers. Afterwards it 
was flushed with PBS to get rid of any blood still present in vessels. Using scissors the 
umbilical cord was cut in pieces (preferably smaller than 0.5 m3 in size), which were 
arranged into 10 small equal piles (approximately 2 spoons). Each pile was then 
transferred into separate culture flask with a spoon. Shortly afterwards, 25 mL of culture 
medium was supplied to each culture flask and the pieces of umbilical cord were evenly 
distributed over the bottom of the flasks. Photographs of the flasks were taken to document 
the amount and size of tissue pieces, after which the flasks were incubated at 37 °C / 5 % 
CO2. Half of the flasks were incubated in normoxic conditions (21% O2), while the other 
half was kept in hypoxia (5% O2) incubator. We used the cells that were incubated in 
normoxia incubator, because all our experiments were also conducted under normoxic 
conditions. 
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Cell outgrowth and medium colour was checked every day and microscopic pictures were 
taken for documentation. Medium was changed every 24-72 h. In case there were a lot of 
red blood cells (RBCs), 1 or 2 initial medium changes were performed in 24 h intervals to 
reduce RBCs.  
Medium change was performed for a maximum of 5 flasks at a time (to prevent drying of 
the outgrown cells due to lengthy procedure). If RBCs settled to the flask bottoms, each 
flask was tilted several times to resuspend the RBCs (to ease their removal). The flasks 
were then put in upright positions. After the tissue pieces sedimented in one corner of the 
flask, the supernatant was removed with a large (25 mL) serological pipette. The pipette tip 
was gently placed on the bottom/edge of the flask to avoid sucking in tissue pieces and the 
supernatant was collected in a (sterile) waste bottle. After the supernatant removal the 
flasks were refilled with 25 mL of fresh medium each. Tissue pieces were again evenly 
distributed over the flask bottoms, before the flasks were put back into the incubator. 
Cell outgrowth from the tissue pieces is normally observed after about 5 to 7 days. Once 
many cells (ca. 70 %) have grown out of the tissue pieces (after 10 to 14 days), the pieces 
were aseptically transferred to fresh T175 flasks. Most of the supernatant was removed and 
the tissue pieces tipped into fresh flasks. New flasks were labelled, supplemented with 25 
mL of fresh medium and cultivated appropriately. 
Adhered cells from the old flasks were harvested and cryopreserved (passage 0) to create a 
working cell bank. Cryopreservation of MSCs was performed under standard protocol, 
routinely used in the research group. If a larger number of cells is needed, the new flasks 
are incubated the same way as the first ones, where cell outgrowth is normally visible after 
about 24-48 h. Once the 2nd round of flasks is ready for harvesting, the tissue pieces can be 
discarded. 
We started our experiment with cryopreserved vials of our cells. 
 
3.3.2 Thawing of MSC and transferring the cells to chemically-defined media 
 
To thaw cryopreserved MSCs we used the adapted procedure, proposed by Freshney 
(2010: 327). Firstly the cell culture medium was prewarmed in water bath in the laboratory 
for Tissue engineering. After the cell sample was located and signed out on Liquid 
Nitrogen Log (online excel sheet), we quickly transferred the cryopreservation vial from 
the liquid nitrogen storage tank (- 180 °C), submerged it into 37 °C water bath and swirled 
it for approximately 1 to 2 min. While the vial was still cool to the touch but completely 
thawed, it was removed from the water bath, sprayed with ethanol (70 %) and placed 
inside a flow hood. We added 1 mL of cold α-MEM to the sample vial and while keeping 
the pipette in our hand, waited for 2 minutes. After 2 minutes the content in the sample vial 
was transferred to 50 mL tube. Sample vial was additionally washed with 2 mL of α-MEM 
and the content was again added to the 50 mL tube with cells. After 2 minutes we topped 
up the tube to 10 mL with α-MEM. Afterwards we centrifuged the tube at 300xg for 5 min. 
Supernatant was suctioned away with sterile Pasteur (glass) pipette. The pellet was flicked 
and then resuspended in 3 mL of cell culture medium. A small fraction was removed for 
cell counting under haemocytometer. After we calculated the cell number, we topped up 
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the cell suspension to 12 mL with cell culture medium and transferred it to T-75 cell 
culture flask. Cells were then incubated at 37 °C/5 % CO2 overnight. After 24 hours we 
changed the medium. 
 
3.3.3 Cell splitting  
 
We designed our cell splitting procedures on a method, proposed by Todaro and Green 
(1963). Before each cell splitting we checked the confluence of our cells under the 
microscope and took photographs for later morphological analysis. We wrote down the 
approximate confluence and examined the cells for any possible morphological changes. 
All the reagents were prewarmed to 37 °C in a water bath. 
We used 2 separate protocols; 1 was used for the first split after the thawing of the cells 
and the second one was used for all the following passages. After we had changed the 
medium in culture flasks, the cells were incubated in the incubator at 37 °C/5 % CO2, until 
they reached the appropriate confluence (above 60 %). We then took them out of the 
incubator and transferred them to the clean bench. All the reagents that were needed in our 
cell splitting were prewarmed to 37 °C, before the start of our procedure. We started cell 
splitting with the removal of culture medium from each of our 2 T-75 culture flasks. The 
flasks were then rinsed with 10 mL of PBS (1x). After a few seconds we removed PBS 
from the flasks and added 4 mL of Sigma dissociation solution. Flasks were incubated for 
approximately 5 min at 37 °C and then tilted gently to force cells to detach. After the 
incubation and tilting we checked the level of detachment under the microscope. If the 
cells remained adhered, we incubated our flasks for additional 2 min at 37 °C and repeated 
the procedure. When the cells were completely detached (~98%), we sterilized outer flask 
surface and transferred them back in sterile environment. We added 6 mL of culture 
medium to each flask and then transferred whole content of each flask (10 mL) into one 50 
mL tube (total volume = 20 mL). After making sure that cells were evenly distributed, we 
split the volume into 4 50 mL tubes (each with 5 mL of cell suspension) and centrifuged 
them for 5 min at 300g. Supernatant from each tube was discarded using Pasteur pipettes 
and suction device and the pellets were resuspended with gentle snipping. Afterwards the 
pellets were additionally resuspended in one of our 4 culture media (Control, TurboDoma, 
Hektor or SCM-1) with 10 % HS and in case of our 3 examined chemically defined media 
(TurboDoma, Hektor and SCM-1) also with 1% GlutaMAX™. In order to get the 
appropriate concentration of cells for the next passage we also performed a cell count 
under the haemocytometer. Consequently we mixed the cell suspension and transferred 
4000 viable cells/cm2 to a fresh cell culture flask (T-25). Fresh culture medium was added 
to each flask to get the total volume of 5 mL and distributed evenly over flask bottom. 
Flask were labelled and moved to the incubator, where they stayed until the next cell 
splitting (at 37 °C and 5 % CO2).  
When cells were moved into 4 different media, we started using smaller T-25 flasks to 
save on material (we had 3 biological replicates (3 flasks) for each examined medium). We 
performed the whole procedure separately for each examined medium, to avoid any 
mistakes or mix-ups. After prewarming reagents to 37 °C, checking confluence of our cells 
and taking photographs under the microscope, we moved our culture flasks in a clean 
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bench. Culture medium was removed from the culture flasks and transferred to 50 mL 
tubes. We then added 5 mL of PBS to wash the cells, and then PBS was also transferred to 
50 mL tubes. After the removal of PBS we added 1.5 mL of Sigma dissociation solution to 
each flask and distributed it evenly over the entire cell layer by tilting the culture vessel. 
Cells were then incubated at 37 °C for approximately 5-10 min and regularly checked for 
cell detachment using a microscope (incubation times lengthened as the serum 
concentration declined). As soon as cells were round and started floating, we added 3.5 mL 
of culture medium in the sterile environment. We used the culture medium to rinse cells 
from the bottom of the flask, and then transferred the whole content to our 50 mL tubes, 
where we already had the residue from the old culture medium and PBS, used for washing 
the cells. After we moved all the cells from T-25 flasks, 50 mL tubes were centrifuged for 
5 min at 300 g. When the centrifugation was finished, supernatant was discarded and the 
pellets were resuspended with gentle snipping. We resuspended the pellets with the 
appropriate amount of culture medium and then performed cell counting with a 
haemocytometer. When we calculated our cell number, we diluted our cell suspension to 
get the right seeding concentration with our medium. Cell seeding concentration was 
adjusted from passage to passage according to cell growth rate in the previous passage. We 
made sure that our cell suspension was evenly distributed over the whole flask bottom. 
Flasks were then labelled (date, cell strain name, passage number, seeding concentration, 
replicate number) and moved to the incubator. Every second passage we also seeded our 
cells onto a 24-well plate for MTT viability test. Cells were seeded at a concentration of 
3500 cells/cm2 (V=1 mL). It was always very important to make sure that the cells very 
evenly distributed through the whole well bottom surface, otherwise the cells accumulated 
in the middle of the well, which could consequently distort the results of the viability test. 
In the second 24-well plate we seeded blanks for each medium. For the blanks we added 1 
mL of each culture medium per well, without any cells. Seeding layout can be seen in 
Figure 5. Cells were incubated for 4 days at 37 °C and 5 % CO2. After the incubation time, 
we performed the MTT viability test as described later in this thesis. 
 
Figure 5: Layout for MSCs, seeded on 24-well plates for MTT analysis. H1, H2, H3 – biological replicates, 
grown in Hektor medium, T1, T2, T3  – biological replicates, grown in TurboDoma medium, S1, S2, S3 – 
biological replicates, grown in SCM-1 medium, C1, C2, C3 – biological replicates for control medium, H, T, 
S, C – wells with blanks for each investigated medium, X – unused wells. 
Slika 5: Razporeditev MMC, nacepljenih na gojilni posodici s 24 vdolbinicam za kasnejši viabilnostni test 
MTT. H1, H2, H3 – biološke ponovitve za gojišče Hektor, T1, T2, T3 – biološke ponovitve za gojišče 
TurboDoma, S1, S2, S3 – biološke ponovitve za gojišče SCM-1, C1, C2, C3 – biološke ponovitve za 
kontrolno gojišče, H, T, S, C – luknjice s slepo probo za vsakega izmed 4 preiskovanih gojišč, X – 
neuporabljene luknjice. 
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3.3.4 Cell counting and viability check 
 
During each centrifugation, we assembled haemocytometer. When the centrifuge had 
stopped, we took 20 µL aliquot from our resuspended cell suspension. We made sure the 
cell suspension was evenly distributed before the aliquot was taken. 20 µL of cells 
suspension was mixed with 20 µL of trypan blue staining solution. The stained cell 
suspension was then transferred to haemocytometer (10 µL/side). We counted cells in 4 
large squares on both sides. Viable (light) and dead (dark) cells were both counted to 
determine cell viability. Once our cells were counted, we calculated cell number, cell 
concentration, viability, population doubling level and the required amount of medium, we 
needed to dilute our cell suspension, if our cell concentration was too high for next 
passage. 
 
3.3.5 Calculation of cell number, population doubling times, population doublings 
and Population Doubling Level 
 
As noted beforehand we needed to calculate the cell number (Equation 1) for each culture 
flask of each cell culture to determine the volume in which we would dilute the cells to 
obtain the correct seeding concentration for the next passage.  
 𝐶𝑒𝑙𝑙  𝑛𝑢𝑚𝑏𝑒𝑟 = 𝑐𝑜𝑢𝑛𝑡𝑒𝑑  𝑐𝑒𝑙𝑙𝑠#𝑙𝑎𝑟𝑔𝑒  𝑠𝑞𝑢𝑎𝑟𝑒𝑠×𝑣𝑜𝑙𝑢𝑚𝑒  𝑓𝑎𝑐𝑡𝑜𝑟×𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛×𝑣𝑜𝑙𝑢𝑚𝑒 …(1) 
Equation cell number in cell suspension. Volume factor – 10000, dilution – 2, volume (of total cell 
suspension). 
From equation for cell growth (Equation 2) we can calculate population-doubling time 
(Equation 3), which is defined as the time (usually in hours) it takes for a certain quantity 
of cells to double in numbers. 
 𝑁 = 𝑁!  ×2 !!! …(2) 
 
 𝑡! =    𝑡log! 𝑁𝑁!  …(3) 
 
Equation for cell growth. N – cell number after cultivation time t, N0 – starting cell number, t – cultivation 
time, tD – population doubling time. 
We also calculated population-doubling level (PDL), which is the standardized way to 
communicate the age of primary cells and is one of the most important parameters of 
clinical cell culture. It gives us the information on how many times the cells divided since 
isolation (Equation 4).  
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 𝑃𝐷𝐿 = 3.32  ×(𝑙𝑜𝑔𝑁 − log𝑁!)+ 𝑆 …(4) 
Equation for population-doubling level. PDL – population doubling level, N – cell number at the end of the 
incubation time, N0 – cell number at the beginning of the incubation time, S – starting PDL. 
 
PDL is very useful parameter in MSC culture, because of the following: 
• MSC growth varies significantly between donors and preparations, therefore we 
should use more precise tools to measure it. 
• PDL values of MSCs have a direct correlation to genomic instability (Pan et al., 
2014). 
• PDL number of MSCs directly correlates with replicative senescence, which is 
linked to the loss of potency (Carlos Sepúlveda et al., 2014). 
• If PDL would be set as a standard in the research of MSCs it would enable better 
comparison and analysis of different studies. 
 
3.3.6 MTT viability test 
 
The MTT assay is a photometric method which enables the determination of metabolic 
activity and thereby the viability of cells. Within the mitochondria, the water-soluble 
yellow colourant MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) is 
reduced to violet coloured Formazan by nicotinamide adenine dinucleotide hydride 
(NADH)(Figure 6). The amount of Formazan crystal formation reflects the metabolic 
activity of the cells and therefore the viability. For photometric detection of the water 
insoluble product Formazan we have to lyse the cells and dissolve the crystals with SDS, 
diluted with HCl. 
 
Figure 6: Chemical structure of MTT and its reduced formazan product (Stockert et al., 2012) 
Slika 6: Kemijska struktura molekule MTT in njegove reducirane oblike formazan (Stockert in sod., 2012) 
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We used the procedure, designed by Denizot and Lang (1986). Firstly we prewarmed PBS 
and basal medium in water bath at 37 °C. We removed the medium from the cells (using 
pump and Pasteur pipettes) and then added 500 µL of PBS per each well. 10 % MTT 
working solution was prepared by adding 60 µL of MTT stock solution to 540 µL of basal 
medium per each well. After the MTT working solution was made, we removed PBS from 
cells (using suction device and Pasteur pipettes). 600 µL of MTT working solution was 
added to each well, then 24-well plate was incubated for 4 h at 37 °C and 5 % CO2. After 4 
h we added 90 µL of SDS solution per well. Cells were then incubated for the subsequent 
24 h, again at 37 °C and 5 % CO2. When 24 h elapsed, we transferred coloured solution 
from each well to a 96-well plate (from each well on 24-well plate to 4 wells on 96-well 
plate; V=100 µL). Absorbance of the coloured solution was determined with a 
spectrophotometer at 570 nm (measurement) and at 630 nm (reference) to exclude media 
effects. We also measured a probe with all reagents but without cells as blank for further 
calculations. 
 
3.3.7 Senescence β-Galactosidase Cell Staining Assay 
 
Senescence β-Galactosidase Staining kit is designed to detect β-galactosidase activity at 
pH 6, a known characteristic of senescent cells not found in presenescent, quiescent, or 
immortal cells (Dimri et al., 1995). Limited capacity to replicate is a defining characteristic 
of most normal cells and culminates in senescence, an arrested state in which the cells 
remain viable (Goldstein, 1990). Senescent cells are not stimulated to divide by serum or 
passage in culture, and senescence invokes a specific cell cycle profile that differs from 
most damage-induced arrest processes or contact inhibition (Sherwood et al., 1988). 
Senescent cells are further characterized by an enlarged cell size, expression of pH-
dependent β-galactosidase activity (Dimri et al., 1995) and an altered pattern of gene 
expression (Cristofalo et al., 1998; Linskens et al., 1995). 
We followed the protocol, designed by Debacq-Chainiaux et al. (2009). We performed 
Senescence β-Galactosidase Cell Staining on cells that were cultivated in control medium 
(α -MEM + 10 % HS). We tested the cells from passages 4, 24 and 26. We wanted to make 
sure that cells would not reach senescent state before we would finish our serum reduction. 
As the whole purpose of serum reduction in MSCs is their later use, either in academic 
research, regenerative medicine, etc., it is necessary that we acquire presenescent cells at 
the end of our experiment. As we have to split the cells many times to reach complete 
serum deletion (18 passages in slow reduction, 10 passages in fast reduction, 10-15 
passages in adjusted reduction), it is reasonable to check if the cells are still presenescent. 
If the cells already became senescent during the serum reduction process, then we would 
have to look for another approach to serum reduction or exclusion in culture media. 
Before we started with our procedure, we prepared at least 6 ml of 1x PBS per 35 mm 
well. Staining Solution was firstly re-dissolved by heating to 37 °C with agitation, then 
diluted with distilled water from 10X concentrated stock Staining Solution to 1x working 
Staining Solution. We needed 930 µL of the 1x staining solution per 35 mm well. We 
diluted 10x Fixative solution to 1x solution with distilled water (1 m of the 1x solution per 
well). 20 mg of X-gal was dissolved in 1 mL of DMF to prepare a 20x stock solution. 
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After we had prepared all the ingredients, we could combine them in a polypropylene 
container to make β-Galactosidase Staining Solution. For each 35 mm well we needed to 
mix 930 µL of 1x Staining Solution, 10 µL of Staining Supplement A, 10 µL of Staining 
Supplement B and 50 µL of 20 mg/ml X-gal in DMF. Due to variations in water pH we 
had to make sure that the solution had a final pH of 5.9-6.1, because the cells only stain at 
that pH value. Once we prepared all our reagents, we removed the growth media from the 
cells and rinsed the plates once with 1x PBS (2 mL for each 35 mm well). 1 mL of 1x 
Fixative solution was added to each well and the cells were allowed to fix for 10-15 min at 
room temperature. We then rinsed the plate twice with 1x PBS (2 mL for each 35 mm 
well) and added 1 ml of the β-galactosidase Staining Solution to each well. Subsequently 
the plate was incubated at 37 °C overnight in a dry incubator (without CO2). After 24 h and 
while the β-galactosidase Staining Solution was still on the plate we checked the cells 
under a microscope (200x total magnification) for the development of blue colour.  
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4 RESULTS 
 
In this chapter we will present all the results that have been obtained during our 
experimental work. We have designed 3 separate experiments. Firstly we started off with 2 
experiments simultaneously. In the first one (slow reduction) we performed 2 cell splits per 
week and 1 serum reduction step, while in the other (fast reduction) serum reduction step 
was carried out during each cell split (2 serum reductions/week). Since we had problems 
with uneven cell growth, due to serum reduction process, we designed another experiment 
(adjusted reduction), in which we only split the cells when the confluence of our cell 
population was high enough (preferably over 70 %). During each experiment we 
monitored cell morphology, viability and cell growth parameters and performed MTT 
viability. On our control cell population we also performed senescence test to determine 
how many passages we can achieve with our uc-MSCs, before they become senescent. All 
the results can be found in the ensuing subchapters. 
 
4.1 ASSESSMENT OF CELLULAR MORPHOLOGY 
 
Before each cell splitting we checked our cells under the microscope to assess any possible 
changes in morphology, estimate the confluence and take photographs for later comparison 
of different passages and between different culture media. 
 
4.1.1 Cells in control medium (α-MEM, supplemented with 10 % HS) 
 
We did not observe any drastic changes in cellular morphology in cells that were kept as a 
control in α-MEM with 10 % HS until very late passages (beyond passage 20), when they 
displayed more flattened, characteristic fibroblast-like morphology (Figure 7). After the 
20th passage, cells grew in size dramatically and it took them much longer to reach 
confluence. 
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Figure 7: Microscopic observation of the morphology of MSCs in control culture medium α-MEM with 10 % 
HS at passages 2, 9, 15 and 25. Apart from passage 25, cells display fibroblast-like morphology with no 
aging-induced morphological changes. 
Slika 7: Mikroskopsko opazovanje morfologije MMC v kontrolnem gojišču α-MEM z 10 % človeškega 
seruma (HS) v pasažah 2, 9, 15 in 25. Celice so z izjemo pasaže 25 izkazovale fibroblastom podobno 
morfologijo brez morfoloških sprememb, povezanih s celičnim staranjem. 
 
4.1.2 Cells, cultured in chemically-defined culture medium SCM-1 
 
In higher serum concentrations, MSCs, which were cultivated in SCM-1 culture medium, 
demonstrated similar cell morphology than the cells that were kept in control conditions. 
When the cells were moved to serum concentrations, lower than 2 %, they became bigger 
in size and also started to change shape (Figure 8). When we lowered serum concentration, 
MSCs also started to grow in distinct bundles of cells, compared to cells in control 
medium, which grew in more-flattened, uniform monolayer. Cells in SCM-1 medium were 
also more difficult to detach, when splitting in lower serum concentrations. When cells 
were cultivated in conditions with less than 2 % of HS, it was impossible to keep our 
schedule that planned 2 passages per week. In the end we even had to resort to cultivate 
cells in 6-well plate, because we could not harvest enough cells for T-25 flasks. At 0.3 % 
HS step we did not harvest even enough cells for 6-well plates. 
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Figure 8: Microscopic observation of the morphology of MSCs in SCM-1 culture medium at passage 3 (10 % 
HS) and 12 (0.5 %). In early stages (at serum content >2 % HS) cells displayed normal cellular morphology, 
comparable to cells in control culture medium, but at serum concentration of 1% and below, cells’ 
appearance changed drastically. 
Slika 8: Mikroskopsko opazovanje morfologije MMC v gojišču SCM-1 v 3. (10 % HS) in 12. pasaži (0,5 % 
HS). V zgodnjih korakih zmanjševanja serumske koncentracije (pri koncentracijah nad 2 % HS) smo pri 
celicah opažali normalno celično morfologijo, primerljivo kontrolnim celicam. Ko pa smo delež seruma 
znižali pod 1 %, smo zaznali drastične spremembe v izgledu celic. 
 
4.1.3 Serum reduction in TurboDoma medium 
 
In passage 3, when cells were firstly cultivated in TurboDoma and supplemented with 10 
% HS, they still displayed normal cellular morphology of hMSCs. They also looked 
similar to cells, cultivated in control culture medium and SCM-1 and Hektor. When we 
checked the cells under the microscope, before we transferred them to fresh medium with 2 
% HS (P6 to P7), they have already grown in size and displayed unidentified secretions, 
which were monitored on top of cell bundles (Figure 9). We did not manage to cultivate 
cells in lower serum concentrations than 3 %.  
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Figure 9: Microscopic observation of the morphology of MSCs in TurboDoma culture medium at passage 3 
(10 % HS) and 6 (3 % HS). In the first step of serum reduction process, when cells were cultivated in 
TurboDoma culture medium, supplemented with 10 % HS, cells displayed normal cellular morphology, 
comparable to cells in control culture medium, but at passage 6 (3 % of HS) cells displayed a much larger 
size and extreme change in shape. At passage 6 it is also possible to see unidentified secreted compounds 
(black arrows). 
Slika 9: Mikroskopsko opazovanje morfologije MMC v gojišču TurboDoma v 3. (10 % HS) in 6. pasaži (3 % 
HS). Ko smo gojišču dodajali 10 % HS so celice v gojišču TurboDoma še izkazovale normalno celično 
morfologijo, podobno kontrolnim celicam. Pri 3 % HS pa so bile celice izrazito večje od kontrolnih celic, 
zaznali pa smo tudi drastično spremembo oblike. V 6. pasaži so s črnimi puščicami označene tudi 
neidentificirane izločene spojine. 
 
4.1.4 Cells, cultured in Hektor culture medium 
 
Cells that were cultured in Hektor culture medium reacted similarly to serum reduction 
than cells in TurboDoma medium. They grew normally, when supplemented with 10 % of 
HS, but started to show changes in size and shape when moved to fresh medium with 
lower serum concentrations (Figure 10). Cells performed a bit better than those, cultivated 
in TurboDoma medium, but still could not be cultivated in conditions, with less than 3 % 
of HS. Also noticed was that when serum concentration was lowered, cells started to grow 
in bundles, in contrast to cells, grown in control medium, which grew in more-uniform 
monolayer. 
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Figure 10: Comparison of cellular morphology of MSCs, cultivated in Hektor culture medium at passage 3 
(10 % HS) and 6 (3 % HS). As seen from microscopic photographs, cells change in size and shape when 
moved to conditions with lower serum concentration. 
Slika 10: Mikroskopsko opazovanje celične morfologije MMC, gojenih v gojišču Hektor v 3. (10 % HS) in 6. 
(3 % HS) pasaži. Kot je dobro razvidno iz mikroskopskih fotografij, so se celice po prenosu v gojišče z nižjo 
vsebnostjo seruma povečale in spremenile obliko. 
 
4.1.5 Cellular morphology of cells, cultivated in different chemically defined media, 
supplemented with 3 % of HS 
 
A more clear comparison of cellular morphology of MSCs, cultivated in different 
chemically defined media and control culture medium can be seen in Figure 11. Cells in 
chemically defined media are displayed at passages with 3 % of HS, while cells in culture 
medium were kept at 10 % of HS. Here we can see, that cells in SCM-1 medium still 
display normal cellular morphology, similar to those kept in control culture medium, while 
cells in TurboDoma and Hektor already show extensive changes in shape and size. 
Throughout the whole culture surface cells in TurboDoma and Hektor culture media grew 
in bundles, with big empty areas, where no cells were present. We also saw distinctive 
contrast intracellular structures in cells that were cultivated in Hektor and TurboDoma 
media. Some cells seemed to have 2 nuclei. 
 
Jan V. Serum reduction approaches in mesenchymal stem cell media. 
   M. Sc. Thesis. Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Biotechnology, 2015 32 
 
Figure 11: Comparison of cellular morphology of MSC at passage 6. Cells in chemically defined media 
(SCM-1, TurboDoma and Hektor) were supplemented with 3 % HS, while cells in control medium were 
cultured with 10 % HS. While cells, cultured in SCM-1 medium, still display similar morphology to cells, 
kept in control medium, cells that were cultivated in TurboDoma and Hektor media already show distinct 
changes in shape and size. It is also possible to see distinctive contrast intracellular structures (black arrows) 
and some cells, cultured in TurboDoma seem to divide their nuclei, but do not divide in whole. 
Slika 11: Primerjava celične morfologije MMC v 6 pasaži. Pri tej pasaži smo celicam v kemijsko definiranih 
gojiščih (SCM-1, TurboDoma in Hektor) dodajali 3 % HS, medtem ko smo kontrolnim celicam še vedno 
dodajali 10 % HS. Medtem ko smo pri tej koncentraciji pri celicah v gojišču SCM-1 še vedno zaznali 
morfologijo, podobno kontrolnim celicam, pa so celice v gojiščih TurboDoma in Hektor že izkazovale 
izrazite spremebe v velikosti in obliki. Pri teh celicah lahko opazimo tudi izrazite kontrastne intracelularne 
strukture (označene s črnimi puščicami), medtem ko smo pri določenih celicah v gojišču TurboDoma opazili 
celice, ki so podvojile svoja jedra, a niso zaključile celične delitve. 
 
4.2 GROWTH CURVE ANALYSES  
 
During each cell splitting we calculated the number of cells and population doubling levels 
(PDLs) for each passage. We used PDL values of each passage to draw charts that show 
cell doublings through the whole length of cell cultivation. Figures 12, 13 and 14 display 
population-doubling levels for slow, fast and adjusted reduction, respectively. As we can 
see from all 3 charts, the only chemically defined medium that supported cell growth for 
longer than 20 days was SCM-1 culture medium. As seen from both slow and fast 
reduction approaches, transfer to TurboDoma and Hektor culture media had a negative 
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effect on MSCs growth, even before we started to significantly decrease serum 
concentration. Population doubling levels dropped as early as at 5 % HS. Cells, cultivated 
in SCM-1 medium showed positive growth till passage 8 (2 % HS) and then slowed down. 
As it was already mentioned before, we stopped passaging cells in SCM-1 medium at 0.5 
% HS, because we could not harvest enough cells for the next split. If we compare all 3 
approaches on the basis of population doubling levels, we can see that PDL values were 
lowest in fast reduction approach (Figure 13), while slow reduction approach and adjusted 
approach performed similarly (Figures 15). In adjusted approach growth curve for hMSCs, 
grown in control culture medium (α-MEM + 10 % HS) looks more uniform, without any 
unusual reduction of growth from day 0 to 60. In slow reduction experiment cells, grown 
in StemCell 1, displayed higher PDL values. PDL values for cell, which were grown in 
TurboDoma and Hektor culture media are missing, because we could not harvest enough 
cells to split the cells in passages with reduced serum content. 
 
Figure 12: Population doubling levels for slow reduction cells, grown in control culture medium (α-MEM + 
10 % HS), SCM-1, Hektor and TurboDoma. 
Slika 12: Populacijski podvojevalni nivoji za celice tekom počasnega zniževanja serumske koncentracije v 
gojiščih SCM-1, Hektor in TurboDoma v primerjavi s kontrolnim gojiščem (α-MEM + 10 % HS). 
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Figure 13: Population doubling levels for fast reduction cells, grown in control culture medium (α-MEM + 
10 % HS), SCM-1, Hektor and TurboDoma. 
Slika 13: Populacijski podvojevalni nivoji za celice tekom hitrega zniževanja serumske koncentracije v 
gojiščih SCM-1, Hektor in TurboDoma v primerjavi s kontrolnim gojiščem (α-MEM + 10 % HS). 
 
Figure 14: Population doubling levels for adjusted reduction cells, grown in control culture medium (α-MEM 
+ 10 % HS) and SCM-1. 
Slika 14: Populacijski podvojevalni nivoji za celice tekom prilagojenega zniževanja serumske koncentracije 
v gojišču SCM-1 v primerjavi s kontrolnim gojiščem (α-MEM + 10 % HS). 
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Figure 15: Comparison of PDL values between slow and adjusted reduction cells, grown in control (α-MEM 
+ 10 % HS), SCM-1, Hektor and TurboDoma culture media. 
Slika 15: Populacijski podvojevalni nivoji za celice tekom počasnega in prilagojenega zniževanja serumske 
koncentracije v gojiščih SCM-1, Hektor in TurboDoma v primerjavi s kontrolnim gojiščem (α-MEM + 10 % 
HS). 
 
4.3 TRYPAN BLUE VIABILITY ASSAY 
 
As it was already stated before, trypan blue viability assays were performed during regular 
cell counting under the microscope. Viability was determined by counting live (light) and 
dead (blue) cells under haemocytometer.  We have calculated viability for each passage of 
our cell cultivation in any of our investigated 3 chemically defined media and in control 
medium (α-MEM + 10 % HS). After we gathered percentage of viable cells for each 
passage, we could calculate the average viability of cells, cultivated in each medium 
through all the passages, from the beginning of cultivation until the cells stopped 
duplicating and started dying out. Average viabilities for hMSCs during slow, fast and 
adjusted serum reduction experiments are presented separately and for each chemically 
defined medium and compared to average viability of cells, kept in control medium with 
constant serum supplementation (10 % HS) (Figure 16, 17 and 18). 
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4.3.1 Viability in slow reduction experiment  
 
In figure 16 we can see that cells, cultivated in control conditions (α-MEM + 10 % HS) 
displayed highest viability through their long-term cultivation (26 passages). Cells, grown 
in SCM-1 culture medium during serum reduction, displayed average viability (in 12 
passages) that was closest to that of control cells (80.6 % ± 8.05). Cells that were 
cultivated in Hektor (and TurboDoma during serum depletion displayed lower average 
viability (69.7 % ± 12.9 and 65.5 % ± 18.5, respectively) and varied more significantly 
from passage to passage (from 50 to 90 % for Hektor and from 35 to 90 % for 
TurboDoma). Cells were cultivated in Hektor and TurboDoma for 6 passages, before they 
died out.  
 
 
Figure 16: Average viability of hMSCs, cultivated in chemically defined media, during slow serum reduction 
experiment compared to an average viability of cells, kept in control medium (α-MEM) with 10 % HS. 
Values are represented as mean ± SD. 
Slika 16: Povprečna viabilnost človeških MMC, gojenih v kemijsko definiranih gojiščih, tekom počasnega 
zniževanja serumske koncentracije v primerjavi s povprečno viabilnostjo celic, gojenih v kontrolnem gojišču 
(α-MEM) z dodatkom 10 % HS. Vrednosti so izražene kot povprečje s standardno deviacijo. 
 
4.3.2 Viability in fast reduction experiment  
 
In fast reduction experiment control cells displayed lower average viability (74.5 % ± 9.41) 
than those cultivated in SCM-1 medium during serum depletion (77.4 % ± 6.35) (Figure 
17). Both cultures were processed for 7 passages. As in slow depletion approach, hMSCs 
that were grown in Hektor and TurboDoma during fast serum reduction showed lower 
viability than both control cells and cells in SCM-1 (Hektor – 67.9 % ± 10.9; TurboDoma 
– 69.3 % ± 10.9). We also experienced bigger variation in viability between separate 
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passages when serum reduction was performed in Hektor (5 passages) or TurboDoma (4 
passages) culture media.  
 
 
Figure 17: Average viability of hMSCs, cultivated in chemically defined media, during fast serum reduction 
experiment compared to an average viability of cells, kept in control medium (α-MEM) with 10 % HS. 
Values are represented as mean ± SD. 
Slika 17: Povprečna viabilnost človeških MMC, gojenih v kemijsko definiranih gojiščih, tekom hitrega 
zniževanja serumske koncentracije v primerjavi s povprečno viabilnostjo celic, gojenih v kontrolnem gojišču 
(α-MEM) z dodatkom 10 % HS. Vrednosti so izražene kot povprečje s standardno deviacijo. 
 
4.3.3 Viability in adjusted reduction experiment 
 
We could only perform serum depletion in SCM-1 medium for adjusted reduction 
experiment, because we could not harvest enough cells for reduction in Hektor and 
TurboDoma culture media. As in slow reduction experiment, average viability of control 
cells was a few % higher than that of cells, cultivated in SCM-1 (80.1 % ± 11.3; 77.19 % ± 
9.58, respectively) (Figure 18). Control cells were cultivated for 25 passages, while cells in 
SCM-1 medium were grown for 8 passages. 
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Figure 18: Average viability of hMSCs, cultivated in SCM-1 medium, during adjusted serum reduction 
experiment compared to an average viability of cells, kept in control medium (α-MEM) with 10 % HS. 
Values are represented as mean ± SD. 
Slika 18: Povprečna viabilnost človeških MMC, gojenih v kemijsko definiranem gojišču, tekom 
prilagojenega zniževanja serumske koncentracije v primerjavi s povprečno viabilnostjo celic, gojenih v 
kontrolnem gojišču (α-MEM) z dodatkom 10 % HS. Vrednosti so izražene kot povprečje s standardno 
deviacijo. 
 
4.4 MTT VIABILITY TEST 
 
We performed MTT viability every second cell split to further evaluate the viability of 
cells during serum reduction process through their metabolic activity. Cells were seeded on 
24-well plate at 3500 cells/cm2. As we can see from figure 5, we had 2 technical replicates 
per each biological replicate (3 for each investigated chemically defined medium + 3 for 
control culture medium). In each of the 3 experiments we have performed, we experienced 
a drastic drop in proliferation rates, when serum concentration was lowered (Figures 19, 20 
and 21). 
 
4.4.1 MTT cell proliferation rates in slow reduction experiments 
 
Compared to average proliferation rate of cells, grown in control medium (0.0592 ± 
0.0280; over 26 passages), cells, which were cultivated in chemically defined media and 
supplemented with 10 % HS, displayed higher proliferation rates (Hektor: 0,2097 ± 
0.0323; TurboDoma: 0.1110 ± 0.0144; SCM-1: 0.1296 ± 0.0039) (Figure 19). 
Supplemented with 5 % of HS, cells in Hektor culture medium still displayed higher 
proliferation rate (0.0787 ± 0.0057), proliferation rate of cells in SCM-1 medium was 
comparable to average rate of control cells (0.0543 ± 0.0055), while proliferation rate of 
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cells in TurboDoma medium already declined drastically to 0.0317 ± 0.0080. When 
chemically defined media were supplemented with 3 % of HS, cells in SCM-1 medium 
were the only ones that still displayed proliferation rates (0.0517 ± 0,017), comparable to 
average proliferation rate of control cells. MTT values of cells in Hektor medium were 
already a lot lower (0.0254), whereas metabolic activity of cells in TurboDoma medium 
barely registered. When we lowered serum concentration to 2 % of HS, even proliferation 
rates of cells in SCM-1 dropped. We managed to grow cells in SCM-1 medium, 
supplemented with as little as 0.5 % HS, but displayed proliferation rates dropped to just a 
fraction of control average. 
 
Figure 19: MTT proliferation rates in slow reduction steps for cells, cultivated in control, Hektor, 
TurboDoma and SCM-1 media. Proliferation rate for control medium presents an average proliferation rate 
over 26 passages. 
Slika 19: MTT proliferacijski nivoji celic, gojenih v gojiščih Hektor, TurboDoma in SCM-1, tekom 
počasnega zniževanja serumske koncentracije. Proliferacijski nivo celic, gojenih v kontrolnem gojišču, je 
predstavljen kot povprečje 26. pasaž. 
 
4.4.2 MTT cell proliferation rates in fast reduction experiment  
 
In fast reduction experiment, serum concentration was reduced twice per week. Because 
we only performed 1 MTT viability test per week, we obtained proliferation rates for only 
every second reduction step (10 %, 3 %, 1 %, 0.3 %) (Figure 20). As it was already 
explained for the slow reduction experiment, proliferation rate for control medium is an 
average calculated from values, obtained during 4 weeks (8 passages) in culture. As seen 
in slow reduction approach, proliferation rates at 10 % HS for cells, cultivated in Hektor 
(0.2097 ± 0.0323), TurboDoma (0.1317 ± 0.0041) and SCM-1 (0.0991 ± 0.0232) were 
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higher than the average proliferation rate of cells, grown in control medium (0.0805 ± 
0.0078). When media were supplemented with 5 % HS, cells in Hektor (0.0483 ± 0.0033), 
SCM-1 (0.0342 ± 0.0029) and TurboDoma (0.0354) all demonstrated lower metabolic 
activity than cells, grown in control medium. As seen in figure 20, at 1 % HS 
supplementation we could only obtain proliferation rate for cells in SCM-1 medium. We 
could not harvest enough cells that were grown in Hektor or TurboDoma media to reach 
such low serum supplementation. 
 
Figure 20: MTT proliferation rates in fast reduction steps for cells, cultivated in control, Hektor, TurboDoma 
and SCM-1 media. Proliferation rate for control medium presents an average proliferation rate over 8 
passages. 
Slika 20: MTT proliferacijski nivoji celic, gojenih v gojiščih Hektor, TurboDoma in SCM-1, tekom hitrega 
zniževanja serumske koncentracije. Proliferacijski nivo celic, gojenih v kontrolnem gojišču, je predstavljen 
kot povprečje 8. pasaž. 
 
4.4.3 MTT cell proliferation rates in adjusted reduction experiment 
  
In adjusted reduction experiment we could only compare MTT proliferation rates for cells, 
cultivated in control and SCM-1 medium, since cells in TurboDoma and Hektor culture 
media reacted really badly to serum reduction. We could not even seed them at 5 % HS 
supplementation. As for the cells that were grown in SCM-1 medium, they displayed 
higher proliferation rate at 10 % of HS (0.1116 ± 0.0164) compared to an average 
proliferation rate of cells in control medium through 16 passages (0.0724 ± 0.0105) (Figure 
21). When cells, cultivated in SCM-1 were supplemented with 3 % HS, their metabolic 
activity was almost equal to the average proliferation rate of control (0.0652 ± 0.019). 
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Cells, grown in SCM-1 with 1 % HS and 0.5 % HS, had proliferation rates of 0.0418 ± 
0.015 and 0.0208 ± 0.006, respectively.  
 
Figure 21: MTT proliferation rates in adjusted reduction steps for cells, cultivated in control and SCM-1 
media. Proliferation rate for control medium presents an average proliferation rate over 16 passages. 
Slika 21: MTT proliferacijski nivoji celic, gojenih v gojišču SCM-1, tekom počasnega zniževanja serumske 
koncentracije. Proliferacijski nivo celic, gojenih v kontrolnem gojišču, je predstavljen kot povprečje 16. 
pasaž. 
 
4.5 SENESCENCE β-GALACTOSIDASE ASSAY 
 
As we have already mentioned beforehand, senescence β-galactosidase assays were 
performed to determine if our hMSCs are still in presenescent state after the completion of 
our serum-reduction processes or do they become senescent even in passages during our 
serum reduction approaches. We used hMSC (code ucMSC130613) in α-MEM culture 
medium with 10 % HS and without antibiotics (control medium in serum depletion 
experiments). The assay was performed on cells from passages 4, 24 and 26, which already 
displayed notable differences in cell size, morphology and growth (Figure 22). 
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Figure 22: hMSCs, cultivated in α-MEM with 10 % HS from passages 4, 23 and 26 before β-Galactosidase 
assay was performed. 
Slika 22: Človeške MMC, gojene v gojišču α-MEM z 10 % HS v 4., 23. in 26. pasaži pred β-galaktozidaznim 
testom. 
 
We performed senescence staining with 2 Senescence β-Galactosidase Staining Kits #9860 
(from Cell Signaling Technology) with different reference dates (03/2013 and 09/2014). 
Staining was performed according to kit’s protocol, which has been described in the 
Methods section of this thesis. We tested old and new kit on separate plates. After we had 
added β-Galactosidase staining solution, we incubated them overnight (37°C, no CO2) and 
then observed the development of blue colour. 
By mistake the pH value of β-galactosidase staining solution was not adjusted. In kit’s 
protocol it is cited that the pH value should be adjusted to 5.9 to 6.1, but our solutions had 
pH values of 6.6 (old kit) and 7.0 (new kit) respectively. Non-adjustment of pH showed in 
the results we obtained (Figure 23).  
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Figure 23: hMSCs stained with β-Galactosidase staining solution without the pH adjustment. Black arrows 
point to clear β-Galactosidase staining (blue) in cytoplasm around nuclei in P26 cells, which confirm 
senescence. Cells in the first row were stained with the old kit, while the ones in second row were stained 
with the new kit. 
Slika 23: Človeške MMC, obarvane z β-galaktozidaznim testom, pred uravnanjem pH vrednosti. Črne 
puščice označujejo jasno obarvane predele citoplazme okrog celičnih jeder v celicah 26. pasaže, kar potrjuje 
pojav senescence. Celice v prvi vrsti so bile obarvane s starim testom, celice v drugi pa z novim. 
 
Positive β-Galactosidase staining was observed only in P26 cells in old and new kit. Not 
all P26 cells showed staining. With the old kit majority of P26 cells stained positive 
(~70%), while only a few (~10%) P26 cells stained positive with the new kit (Figure 24). 
  
O
ld
 k
it 
N
ew
 k
it 
Jan V. Serum reduction approaches in mesenchymal stem cell media. 
   M. Sc. Thesis. Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Biotechnology, 2015 44 
  
Figure 24: hMSCs stained with β-Galactosidase staining solution without the pH adjustment. Black arrows 
point to clear β-Galactosidase staining (blue) in cytoplasm around nuclei in P26 cells, which confirm 
senescence. 
Slika 24: Človeške MMC, obarvane z β-galaktozidaznim testom po prilagoditvi pH vrednosti. Črne puščice 
označujejo jasno obarvanje citoplazme okrog celičnih jeder v celicah 26. pasaže, kar potrjuje pojav 
senescence v teh celicah. 
 
When we realised that pH values were not adjusted, we further stained the identical plates 
with the same staining solution, but the pH values were adjusted to ~pH 6.0 by addition of 
200 µL of 10 mM HCl in ddH2O per well. As a result we obtained good staining in both 
old and new kit (Figure 26). P26 cells were stained in great numbers, while lighter staining 
was observed in P24 cells. Only a few of P4 cells were faintly stained. 
 
Figure 25: hMSCs stained with β-Galactosidase staining solution after the pH adjustment to 6.0. 
Slika 25: Človeške MMC, obarvane z β-galaktozidaznim testom, po uravnanju pH vrednosti na 6,0. 
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5 DISCUSSION 
 
Human mesenchymal stem cells (hMSCs) are surfacing as an important therapeutic tool in 
cell therapy. For any effective treatment that utilizes MSCs, we need a large amount of 
cells, which we can nowadays easily propagate in in vitro culture in basically any properly 
equipped laboratory. On the other hand the stability, regenerative effect and safety of such 
cells remain debatable. Therefore to further advance the role of stem cells in regenerative 
medicine and cell-based therapeutics it is absolutely necessary to develop new or refine the 
existing expansion protocols.  It is also recommended to remove all undefined substrates 
and reagents from our cell culture, which could introduce variability in experimental 
results and affect the uniformity, safety and efficacy of the designed product. 
The goal of our experiment was to investigate the possibility of weaning hMSCs from 
serum-supplemented medium to 3 different serum-free media (SCM-1, Hektor and 
TurboDoma) and to determine the effects of serum depletion on cellular morphology, size, 
viability, metabolic activity and metabolic activity. Even though we have been unable to 
completely remove HS from culture media, we have also obtained many interesting data, 
that is discussed in the following subchapters. 
 
5.1 SERUM DEPLETION APPROACHES 
 
We designed 3 separate serum depletion experiments. We started with slow and fast 
reductions that were based on gradual reduction approach. Gradual reduction approach is 
one of the proposed adaption protocols to aid the process of weaning (van der Valk et al., 
2010). Slow reduction experiment was designed in a way that we passaged hMSCs twice 
each week, while serum concentration was only lowered once per week. In fast reduction 
experiment serum concentration was lowered twice per week (at every passage). In slow 
reduction, hMSCs were kept at a certain serum concentration for additional passage (2 
passages per each serum reduction step), so the cells had more time to adapt to lower 
serum conditions. As giving the cells another passage to adapt to the adjusted conditions 
accumulates in longer weaning process (18 passages), hMSCs would be in a very late 
passage, when we could finally use them for our academic research or therapeutic 
purposes. Even though hMSCs from young donors can undergo between 24 to 40 
population doublings (PD), which in our case correlates to passages 22-26, before their 
growth ceases and they become senescent (Kassem, 2006), it is advisable to expand cells 
in as few passages as possible. Cells from lower passages are less likely to contain genetic 
abnormalities and have a higher proliferative capacity. Wang et al. (2013) reports that 
hUC-MSCs, cultivated in long-term culture develop genomic alterations, so it is best to 
strive towards serum depletion protocols that do not require very long-term cell culture. 
That is why we also performed fast reduction experiment, which takes 10 passages before 
we reach 0 % of serum.  
Both approaches had their positive and negative aspects. As we have already mentioned 
the negative aspect of slow reduction is its long procedure, during which the cells could 
undergo genomic and epigenetic changes, or the cells could become senescent. On the 
other hand, the cells did have more time to adapt to each serum reduction step, which 
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increased their chances of survival. The positive side of fast reduction was that as noted 
before we only needed 10 passages to completely remove serum from our cell culture, but 
as we have observed ourselves, cells did not have enough time to adapt to stressful 
conditions of lower serum supplementation. In accordance with our hypothesis, the added 
adaptation passages in slow reduction approach contributed to cells, cultivated in 
chemically defined media, to survive longer during serum depletion process. Those 
hMSCs, grown in TurboDoma and Hektor media still divided at 5 % of HS, while the cells 
in SCM-1 culture medium grew at 1 to 2 % of HS. In fast reduction approach negative 
aspects seemed to outbalance the positive ones, since the cells ceased growth almost 
immediately after being transferred from control medium with 10 % HS to chemically 
defined media. 
After we had to cease the fast experiment because of dwindling cell numbers, we designed 
a third adjusted approach. We decided that we would not keep to a strict schedule like in 
the slow and fast experiments where cells were split twice a week, no matter the 
confluence they reached. That gave us more manoeuvrability. We could prolong the 
incubation time, if the cell growth was not fast enough to reach the required confluence or 
shorten it if the cell population doubling time was shorter than expected. Because of our 
experience with first 2 experiments, we could also manage seeding concentrations better 
and avoid over-confluent cultures, where we would get large clumps of cells, which would 
be impossible to properly detach and resuspend for next passage. With this approach we 
would also avoid inaccurate cell numbers and low viability that would arise as a 
consequence of filtering big clumps of cells away from our cell suspension. 
We detected many practical problems that arose as a consequence of serum-depletion 
procedure. The biggest by far was the difficult detachment of cells during cell passaging, 
when serum concentrations reached lower values. While hMSCs detached normally in 
culture with high percentage of HS, they stuck firmly to the surface when serum 
concentration was lowered below 5 % for cells in Hektor and TurboDoma culture media 
and 2 % for cells in SCM-1. On the suggestion of chemically defined media manufacturer 
we used Sigma’s non-enzymatic cell dissociation solution, which was supposed to be less 
aggressive than trypsin. From our experience we can conclude that Sigma’s non-enzymatic 
solution did not perform as well as planned. As we have lowered serum concentration in 
our cell cultures, the incubation time for detachment got longer (more than 10 min). Even 
with longer incubation time, a large number of cells seemed to remain attached to the 
surface. That meant that we obtained lower harvesting numbers, which in later passages 
made it even more difficult to collect enough cells for the next reduction step. We can also 
conclude that fixed passaging schedule in fast and slow reduction was too rigid and it 
actually contributed to stressful conditions. Because it was very hard to determine the 
appropriate seeding concentration, our cell cultures were sometimes too confluent, which 
resulted in cell clumps and difficult detachment, or growth was too slow and our cultures 
were less than 40 % confluent, which might have meant that cells were still in their lag 
phase. As cell cultures should be in their logarithmic phase and demonstrate viability over 
90 %, passaging cells in lag phase could have a cascading effect on the following serum 
depletion steps.  
As we have already mentioned, we have solved some issues, arising during slow and fast 
reduction, with the design of the third adjusted reduction approach. But even though we 
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had solved the problem of over-confluent culture flasks and had given the cells more time 
to reach logarithmic phase, our chemically defined media still could not support cell 
growth without any serum supplementation. For cells, grown in Hektor and TurboDoma 
we had to stop the experiment at 3 % HS supplementation, while cells, cultivated in SCM-
1 medium, survived at lower serum supplementation (0.5 %). We have to point out that at 
lowest possible serum supplementation that still supported cell growth, hMSCs 
demonstrated many signs of stress, which resulted in change of cellular morphology, size, 
growth rates and metabolic activity.  
 
5.2 CELLULAR MORPHOLOGY  
 
Serum reduction procedures had a drastic effect on cellular morphology of hMSCs in 
chemically defined media. While hMSCs still displayed a similar morphology to those, 
grown in control medium with 10 % HS, while cultivated with higher serum 
supplementation (5 % HS for Hektor and TurboDoma; 2 % for SCM-1), the changes 
became more apparent when we lowered serum concentration to 3 % for cells that were 
grown in Hektor and TurboDoma media, and to 1 % for cells, which were cultivated in 
SCM-1 medium (Figures 7, 8 and 9). In our microscopic observations we have witnessed a 
significant increase in cell size that correlated with gradual serum reduction procedures. 
We also spotted a change in shape. While at 10 and 5 % of serum supplementation, cells, 
cultivated in chemically defined media, still demonstrated fibroblast-like morphology, they 
became more elongated at lower serum concentrations and we could also spot distinctive 
contrast intracellular structures (Figure 10). Cells also started to grow in bundles and we 
could spot large areas without any cell growth in our culture flasks. At lower serum 
concentrations we witnessed unidentified secreted compounds that floated on top of 
hMSCs. The two most realistic speculations are that these were excessive matrix 
depositions, which occurred as a response to cell stress, or that this was debris from dying 
cells, trapped in matrix that was produced by the cells. Because the debris was trapped in 
matrix, it could not float freely but stuck with the cells. In TurboDoma cell culture with 
low serum supplementation we also spotted cells that undergone nuclear division but did 
not go through with cell division. This could be a result of missing compounds from 
serum, which the composition of chemically defined medium does not replace. 
Changes in morphology can be attributed to the reduction of serum concentration in 
chemically defined culture media. We do not know the exact mechanisms that cause the 
changes in morphology, so further investigation into metabolic and genetic changes, 
caused by serum reduction, should be performed to gain more insight into the matter. 
 
5.3 CELL GROWTH PARAMETERS 
 
During each cell splitting we also performed cell counting and viability assessments with 
trypan blue staining. Each passage we calculated the number of cells, their doubling times 
and population doublings (PD). When the experiments were stopped we also calculated 
population-doubling levels (PDL). We needed the data on number of cells to determine the 
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right dilution volumes to set the right seeding concentrations and we needed PDL values to 
determine the number of doublings our cells undertook before reaching senescence.  
We obtained the best results in slow and adjusted reductions, while fast reduction did not 
exhibit good proliferation of cells, cultivated in chemically defined media. It is important 
to point out that even in slow and adjusted reduction, hMSC cultures in chemically defined 
media, which had undergone the serum depletion process, did not perform even close to 
those, kept in control medium (with 10 % HS). From PDL values, calculated from cell 
counting, we see that control cells displayed a uniform growth, which only declined at 
certain passages, where we had to filter large clumps of cells away from our cell 
suspension. As a consequence of filtering we harvested just a small fraction of cells that 
actually grew in that passage. In reality growth in control cell culture only ceased at later 
passages (after passage 20) when cells reached senescence. The senescence of control cells 
at long-term cultivation was later also confirmed with senescence β-galactosidase assay. 
With PDL values we obtained a very valuable data that confirmed effects of serum 
depletion procedures on cell doubling. Human MSCs that were cultivated in Hektor and 
TurboDoma hardly even divided, after they were transferred from control medium to 
chemically defined media with the same serum concentration. While we can say that low 
harvest numbers in first passage after the transfer from control medium was due to 
overconfluent cultures that lead to us using the filters to remove huge clumps of cells, low 
harvested cell number in the consequent passages can be attributed to lower serum content 
and composition of chemically defined media. As we have already discussed it in cellular 
morphology evaluation, serum depletion seemed to result in cells transferring their energy 
to growth in size rather than cell division. 
From all 3 chemically defined media, SCM-1 seemed to be the only 1 that supported cell 
doublings even at lower serum concentration. In slow reduction experiment, cells in SCM-
1 medium undergone 8.5 doublings before they started to die out (at passage P8 and at 
serum concentration of 2%), in fast reduction they barely divided after we started to reduce 
serum concentration, while in adjusted reduction cells performed slightly less doublings 
(7.6), but also divided at lower serum concentration (1 %).  
Calculated viabilities of cells from all 3 experiments correlated with all other obtained 
data. All cells that went through serum depletion in chemically defined media displayed 
lower viability, which additionally dropped when cells were transferred to passages with 
lower serum supplementation. Cells in chemically defined media were also more 
susceptible to any stress that could occur during cell handling, which resulted in bigger 
variations through different passages. This was expected, as we had come across many 
articles that pointed out this drawback (Jayme and Gruber, 2006; van der Valk et al., 2010; 
Jung et al., 2012). 
 
5.4 MTT VIABILITY ASSAYS 
 
We performed MTT viability assays to obtain valuable data on metabolic activity and 
thereby viability of cells. MTT proliferation rates complemented the PDL values that we 
have obtained during cell counting with trypan blue staining. MTT viability assay is also 
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perfect for measuring reduction in cell viability, when metabolic events lead to apoptosis 
or necrosis.  
Surprisingly in all 3 reduction experiments cells, grown in chemically defined media 
(TurboDoma, Hektor and SCM-1) with 10 % HS displayed higher proliferation rates, 
compared to those, cultivated in control medium. This could be explained with high 
nutritional values of chemically defined media, especially of Hektor and TurboDoma, 
which are normally used for the propagation of several kidney-derived mammalian cell 
lines and for the production of monoclonal antibodies with hybridomas. Nutrient strength 
of SCM-1 is also supposed to be comparable to that of Hektor culture medium. It seems 
that high nutritional value of chemically defined media and diverse composition of serum 
result in significant shortage of doubling time at higher serum concentration. 
Nevertheless when we lowered serum concentration proliferation rates of cells in all 3 
chemically defined media and in all 3 reduction experiments started to drop. Proliferation 
rates seemed to drop the fastest for the cells that were cultivated in TurboDoma. Even at 
cultivation, supplemented with 5 % of HS, their proliferation rate was half of the average 
rate of control cells’. At 5 % HS cells in Hektor culture medium displayed higher 
proliferation rate compared to average proliferation rate of control cells, but only in slow 
reduction experiment. The only hMSCs, that showed comparable proliferation rate to the 
average of control cells at 3 % HS supplementation, were those grown in SCM-1 medium. 
At 1 % serum concentration even the latter displayed very low proliferation rates in slow 
and fast reduction experiment, while in adjusted approach the proliferation rate of SCM-1 
cells equaled to about two thirds of the average proliferation rate of control cells.  
We can conclude that none of our 3 chemically defined media supports serum-free 
cultivation of hMSCs that were isolated in serum-supplemented media and undergone 
gradual serum reduction. 
 
5.5 SENESCENCE β-GALACTOSIDASE ASSAY 
 
With senescence β-galactosidase assay we wanted to determine if hMSCs from our 
experiments could theoretically still be useful for academic research or therapeutic 
purposes after the performed weaning. We performed staining on hMSCs from passages 4, 
24 and 26, which were cultured in control medium with 10 % HS. Cells demonstrated 
differences in cellular morphology and with senescence staining we could determine the 
correlation of changes in morphology with the occurrence of senescence. We used two kits 
with different reference dates (old and new) to achieve the staining. After the first 
overnight incubation we achieved barely any staining and only in P26 cells. That was later 
attributed to our mistake, because we had missed to adjust the pH, which is essential to β-
galactosidase staining. Once the pH was adjusted, we stained the same cells with the same 
staining solution and this time acquired strong staining in P26 cells, mild staining in P24 
cells and light staining in some P4 cells. From this we can conclude that hMSCs, which 
have undergone serum depletion through our reduction procedures, could technically still 
be used for research or therapeutic purposes, but with limited capacity. In all 3 serum 
reduction experiments, cells had to go through more than 10 passages, before they would 
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get to serum-free conditions and that would only give us approximately 10 more passages 
before hMSCs would become senescent.  
 
5.6 NEXT STEPS 
 
As none of our 3 chemically defined media supported serum-free cultivation without any 
additional supplementation and with gradual serum reduction we have to determine next 
steps. We could further optimize the best of our 3 investigated media SCM-1 (Stemcell 
Cell Medium 1), try out the direct adaptation, which could result in smoother adaptation to 
serum-free conditions, determine the essential supplements (eg. bFGF) or find other better 
defined supplements for HS. We could also perform additional analysis to get a deeper 
insight into the effects of serum reduction on cell metabolic activity, changes in cellular 
morphology, cell growth and genomic changes.  
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6 CONCLUSIONS 
 
• None of our 3 chemically defined media could support hMSC cultivation in 
conditions without HS supplementation. 
 
• During all 3 serum depletion experiments we monitored cellular morphology, 
viability, cell growth parameters, senescence and metabolic activity. All the 
monitored parameters pointed towards the fact that serum depletion process puts 
hMSCs under great stress. As a result of stress, cells changed their morphology 
from small spindle-shaped to bigger fibroblast like cells, their viability dropped 
considerably with the reduction of serum concentration, growth also slowed down 
and eventually stopped (at 3 % HS for Hektor and TurboDoma and at 0.5 % HS for 
SCM-1) and metabolic activity dropped at lower HS supplementation.  
 
• SCM-1 chemically defined culture medium performed best of the 3 chemically 
defined media. But even though we managed to cultivate cells in SCM-1 medium 
with as little as 0.5 % HS, changes in cellular size and shape, lower proliferation 
rates, lower population doubling levels and higher mortality showed that SCM-1 
chemically defined medium did not alone provide enough constituents that would 
support cell cultivation without the presence of HS. The same can be said for the 
other two chemically defined media. 
 
• A lot of practical problems arose, because of serum depletion processes. We had to 
be very careful when we were operating with hMSCs, since any mechanical stress 
on cells would results in a drop of viability. 
 
• According to the senescence β-galactosidase assays the investigated hMSCs only 
became senescent around passage P26, so technically if we would manage to 
gradually reduce serum concentration in our chemically defined media to 0 %, the 
cells could still be used for academic or clinical purposes. 
 
• Because we would eventually like to completely eliminate serum from medium 
formulations and since there is a possibility that serum-derived contaminants are 
carried over with the cells when they are transferred to serum-free conditions (Jung 
et al., 2012), the next step should be a direct transfer to serum-free medium after 
the cells have been isolated (in our case from umbilical cord blood). 
 
• All 3 investigated media have to undergo additional optimization before they could 
support serum-free cultivation of hMSCs. 
  
Jan V. Serum reduction approaches in mesenchymal stem cell media. 
   M. Sc. Thesis. Ljubljana, University of Ljubljana, Biotechnical Faculty, Academic Study in Biotechnology, 2015 52 
7 SUMMARY (POVZETEK) 
7.1 SUMMARY 
 
Human mesenchymal stem cells (hMSCs), also referred to as mesenchymal stromal cells, 
have been evaluated for different clinical purposes, because of their multipotentiality, 
secretion of bioactive factors, tropism for sites of disease, immunomodulation and immune 
privileged or hypoimmunogenic properties. Because the number of hMSCs in is extremely 
low compared to other nucleated cells in all tissues where they are found, it is crucial that 
we expand them in in vitro conditions to obtain sufficient numbers for later experimental 
or clinical use. In normal practice hMSCs are propagated in culture media that ordinarily 
consist of basal medium (e.g. α-MEM, DMEM, Ham’S F12, RPMI 1640), supplemented 
with different percentage of human or animal-derived serum (5-15 % (v/v)). Even though 
serum as a supplement provides many advantages to the media, such as universality for 
cultivating many different types of cells, good protection against mechanical stress and 
buffering, there are also many disadvantages, caused by its presence. Because of its 
unidentified composition, high retail price, contamination risks and lot-to-lot variability it 
makes it impossible for us or anyone else to reproduce our experimental results or clinical 
efficacy of our hMSCs. That is why it is essential that we develop chemically defined 
media and approaches for serum-free cultivation that will enable us to increase the 
reproducibility in the field of stem cell research, eliminate or lower the variability in the 
clinical performance and further accelerate the progress of regenerative medicine. 
In our thesis we have designed 3 different approaches for serum reduction in 3 chemically 
defined media for hMSC cultivation, called Hektor, TurboDoma and StemCell cell 
medium 1 (SCM-1). The effects of serum reduction process on cell performance, 
morphology, growth rate, viability, size and metabolic activity was compared to hMSCs, 
which were cultivated in control culture medium (α-MEM) with a constant human serum 
(HS) supplementation (10 %) Because our cells were already isolated in serum-
supplemented media, we have decided to perform gradual reduction, which would give 
hMSCs more time to adapt to lower serum conditions and eventually grow in serum-free 
environment. We have performed slow, fast and adjusted reduction experiments. In slow 
reduction approach we have split the cells twice a week and lowered serum concentration 
every second passage, while in the fast reduction experiment serum concentration was 
lowered every cell split (i.e. twice per week). After the first 2 experiments, we have 
performed the third one that was supposed to combine the best characteristics of the first 
two. Here we performed serum reduction step during each passaging, but cells were only 
split, when they reached an appropriate confluence (preferably above 60%). That would 
lower the danger of diluting our cells, due to hurried cell splits, before the hMSCs reached 
logarithmic phase and enable us to finish the serum reduction in lesser number of passages 
than in slow reduction experiment. During each cell split we have monitored cellular 
morphology and size, calculated cell numbers, population doublings and evaluated 
viability, while every second passage we have also performed MTT viability assays that 
measure viability through cellular metabolic activity. 
Through all the monitored parameters we have observed that the serum reduction 
procedures had negative effects on hMSCs, cultivated in all chemically defined media. The 
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most drastic changes in analysed parameters were seen in cells, grown in TurboDoma 
culture medium (under 5 % HS), followed by cells, grown in Hektor (under 5 % HS), 
while cells in SCM-1 medium seemed to be least effected of the 3. That is of course until 
we have lowered serum concentration under 2 %.  
In cellular morphology the effects of the reduction culminated in transition from traditional 
spindle-shaped (or fusiform) and cuboidal fibroblast-like cells to much larger non-
uniformed cells that varied greatly in shape and size. This transition was observed after the 
cells were transferred to media, supplemented with 3% HS (Hektor and TurboDoma) and 1 
% HS (SCM-1), respectively. In cells, grown in TurboDoma medium with 3 % HS, we 
have also spotted some cells, that divided their nuclei, but did not divide into 2 cells.  
We calculated population-doubling levels (PDL) from cell countings under 
haemocytometer that were performed before each cell split. This was done for later 
comparison of cell doublings, our cells performed during each passage and over the whole 
cultivation. At the same time we also performed trypan blue staining assay to determine 
viability. From PDL curves, we witnessed that hMSCs in TurboDoma and Hektor medium 
performed most of their doublings, before serum concentration was lowered (to 5 % HS). 
After we lowered serum concentration, they stayed viable, but basically just grew in size. 
Cells, cultivated in SCM-1 medium did perform doublings until they were supplemented 
with less than 2 % of HS, after which cell proliferation dropped and eventually ceased at 
0.5 %. From 3 reduction approaches we got the best results in slow and adjusted reduction, 
while the fast reduction seemed to be too stressful and did not give hMSCs enough time to 
adapt to lower serum concentration. Cells that were cultivated in control medium (α-MEM 
+ 10 % HS) were the only one that displayed a constant cell proliferation till later passages 
(after passage 20).  
From trypan blue staining we obtained average viability of cells in different media over the 
whole length of their cultivation. Again hMSCs that were subject to serum reduction in 
chemically defined media, showed lower average viability compared to control cells. Over 
all 3 serum reduction experiments cells in Hektor and TurboDoma displayed lowest 
average viability (and over shortest cultivation time) with the highest rate of variability 
between passages. Average viability of cells from SCM-1 medium was only a bit smaller 
compared to those in control medium.  
MTT viability assay results correlated to those, obtained with other analytical methods. 
While proliferation rates of hMCS, grown in chemically defined media, were even higher 
at 10 % HS supplementation compared to the average proliferation rate of those, grown in 
control medium, they gradually reduced over serum reduction. At 5 % serum 
supplementation, cells, cultivated in Hektor and TurboDoma still displayed similar or 
slightly lower proliferation rates, compared to the average of control cells. Cells, grown in 
SCM-1 performed even better. Their proliferation rate was still equal to average 
proliferation rate of control cells at 3 % supplementation.  
We also performed senescence β-galactosidase staining assay to determine if the cells 
reach senescence before we complete all our reduction steps. We stained cells from 
passages 4, 24 and 26. Cells in passage 26 displayed strong blue staining, while cells in 
passage 24 showed moderate staining, Cells in passage 4 remained basically unstained. 
Results of our senescence assay showed that if we would manage to eliminate serum from 
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our chemically defined media with our gradual reduction approaches, we could still 
perform 6-14 passages at most before hMSCs would become senescent. The number of 
remaining passages depends on the serum reduction approach (6 for slow reduction, 14 for 
fast). 
All the assays that we have performed during our serum reduction procedures lead us to 
the conclusion that none of our 3 chemically defined media can support serum-free 
cultivation of hMSCs, when the serum-supplemented medium is used in the isolation and 
cryopreservation procedures and gradual serum reduction is performed. High proliferation 
rates of cells in chemically defined media at 10 % HS can be linked to high nutritional 
value of chemically defined media, which are in case of Hektor and TurboDoma normally 
used for the cultivation of several kidney-derived mammalian cell lines and for the 
production of monoclonal antibodies with hybridomas. Nevertheless once we started to 
lower serum concentration, proliferation rates, population doubling levels, viability 
dropped and the morphology of cells changed drastically. The cause of these changes can 
be attributed to the combination of factors, which include stress during serum reduction 
process, unsuitable dissociation solution, hasty reduction process that does not allowed 
cells to adapt to lower serum concentrations, unsuitable reduction approach and usage of 
serum-supplemented media in isolation and cryopreservation. 
In our thesis we have set many cues for further investigation of serum-free cultivation in 
chemically defined media. Even though none of the 3 researched media could support 
completely serum-free proliferation, SCM-1 still showed promise that if we use an 
appropriate serum reduction or exclusion approach, adjust the formulation of medium or 
add certain growth factors that are known to support stem cell proliferation when added to 
serum-free media (bFGF), it could actually support serum-free proliferation of hMSCs. We 
could also perform additional analyses, such as evaluation of surface antigen expression 
with flow cytometry, karyotyping and comparative genomic hybridization to gain more 
insight into what happens with hMSC during serum-reduction procedures. We were 
planning to perform some of these methods during our experimental work, but due to very 
labour intensive experiment design, we had decided to focus on metabolic activity, 
morphology, growth rate and viability assessment that would set the foundation for further 
research. 
 
7.2 POVZETEK 
 
Človeške mezenhimske matične celice (hMSC), poimenovane tudi mezenhimske 
stromalne celice, so predmet številnih kliničnih raziskav zaradi njihove multipotentnosti, 
izločanja biološko aktivnih dejavnikov, tropizma k območju bolezni, imunomodulacije in 
hipoimunogenih lastnosti. Ker hMSC v vseh tkivih, kjer jih najdemo, predstavljajo le zelo 
majhen delež mononuklearnih celic, jih moramo pred kakršno koli kasnejšo uporabo v 
raziskovalne ali klinične namene predhodno namnožiti v in vitro pogojih do primernih 
koncentracij. Običajno hMSC gojimo v gojiščih, ki temeljijo na bazalnih gojiščih (npr. α-
MEM, DMEM, Ham’S F12 in RPMI 1640), ki jim dodajamo različne odstotke človeškega 
ali živalskega seruma (najpogosteje 5-15 % (v/v)). Čeprav nam serum kot dodatek 
zagotavlja številne ugodnosti, kot so univerzalnost gojišča za gojenje številnih različnih 
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tipov celic, dobra zaščita proti mehanskemu stresu in velika puferska kapaciteta, pa nam 
njegova prisotnost prinaša tudi številne slabosti. Zaradi neznane sestave, visoke cene, 
tveganja okužb in variabilnosti od serije do serije, nam prisotnost seruma v gojiščih 
onemogoča ponovljivost eksperimentalnih rezultatov ali konstantnost klinične 
učinkovitosti hMSC. Zatorej je nujno, da stremimo k razvoju kemijsko definiranih gojišč 
in pristopov za brezserumsko gojenje. Gojenje v gojiščih brez vsebnosti seruma bo 
izboljšalo ponovljivost rezultatov na področju matičnih celic, izboljšalo klinično 
učinkovitost terapevtskih proizvodov, ki temeljijo na hMSC, olajšalo izolacijske procese, 
zmanjšalo možnost okužb, pocenilo naše raziskave in še pospešilo razvoj znanstvenega 
področja. 
V našem magistrskem delu smo zasnovali 3 različne pristope zniževanja serumske 
koncentracije v 3 kemijsko definiranih gojiščih za gojenje hMSC. Uporabljali smo gojišča 
Hektor, TurboDoma in StemCell cell medium 1 (SCM-1), ki nam jih je priskrbelo 
švicarsko podjetje Cell Culture Technologies. Učinke postopkov zniževanja serumske 
koncentracije na učinkovitost, celično morfologijo, hitrost rasti, viabilnost, velikost in 
metabolno aktivnost smo primerjali s celicami, ki so bile gojene v kontrolnem gojišču (α-
MEM) z dodanim človeškim serumom (HS) (v konstatni koncentraciji 10 %). Ker so bile 
naše hMSC že izolirane in zamrznjene v gojiščih, ki so vsebovale serum, smo se odločili 
za pristop postopnega zmanjševanja vsebnosti seruma. S tem smo želeli zmanjšati stresne 
pogoje, ki se pojavijo zaradi zmanjševanja vsebnosti seruma in dati celicam več časa, da se 
postopoma prilagodijo na brezserumske pogoje. Izvedli smo hitro, počasno in prilagojeno  
postopno zmanjševanje vsebnosti seruma. Pri počasnem zmanjševanju smo hMSC 
nacepljali dvakrat na teden, medtem ko smo koncentracijo seruma znižali le vsako drugo 
pasažo (enkrat na teden). S tem smo celicam zagotovili dodatno pasažo pri isti 
koncentraciji seruma in dodaten čas za prilagoditev na nižjo vsebnost seruma. Pri hitrem 
zniževalnem pristopu smo celice prav tako nacepljali dvakrat tedensko, vendar smo ob 
vsaki pasaži znižali tudi koncentracijo seruma. Pri tem pristopu smo želeli ugotoviti, če je 
celice možno odvaditi od vsebnosti seruma brez dodatnih pasaž za prilagoditev. Če bi 
celice namreč privadili na brezserumske pogoje v krajšem času, bi nam preostalo več 
nacepljanj (pasaž) za kasnejše raziskovalno delo ali namnoževanje celic za klinično 
uporabo, preden bi celice zapadle v senescenco. Za prvima dvema pristopoma smo razvili 
še tretjega, ki smo ga poimenovali prilagojeni pristop. S prilagojenim pristopom smo želeli 
zajeti prednosti prvih dveh pristopov in se izogniti slabostim, na katere smo naleteli tekom 
našega dela s prvima pristopoma. V prilagojenem pristopu zniževanja smo se odločili v 
prvih stopnjah koncentracijo seruma zniževati vsako pasažo, vendar smo celice ponovno 
nacepljali le, ko so te dosegle zadostno konfluenco (nad 60 %). S tem smo se želeli izogniti 
redčitvi in nacepljanju celic, preden te desežejo logaritemsko fazo rasti. S tem, ko smo v 
prvih korakih, ko je vsebnost seruma v gojiščih še visoka, koncentracijo seruma znižali 
vsako pasažo, pa smo se izognili prekomernemu številu pasaž, ki nam zmanjšajo vrednost 
in smiselnost naših hMSC za kasnejše raziskovalne ali terapevtske namene. V primeru, da 
bi pri nižjih vsebnostih seruma zaznali stagnacijo rasti, pa bi se še vedno lahko odločili za 
dodatno pasažo pri isti koncentraciji seruma, kar bi dalo celicam dodaten čas za 
prilagoditev. Med vsakim nacepljanjem smo preverjali: 
• Morebitne spremembe celične morfologije. 
• Velikost celic. 
• Število celic. 
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• Število populacijskih podvojitev. 
• Viabilnost. 
• MTT viabilnostne teste, s katerimi smo merili metabolno aktivnost celic (izvedeni 
vsako drugo pasažo). 
Preko vseh merljivih dejavnikov smo zaznali, da ima zniževanje serumske koncentracije 
izrazito negativne učinke na hMSC, ki so bile gojene v kemijsko definiranih gojiščih. 
Najbolj izrazite spremembe smo zaznali v celicah, ki so bile gojene v gojišču TurboDoma 
(pod 5 % HS), tem so sledile celice v gojišču Hektor (pod 5 % HS), medtem ko so celice v 
gojišču SCM-1 kazale še najmanjše negativne učinke od vseh 3 gojišč. Treba pa je 
poudariti, da so se tudi pri hMSC v tem gojišču pokazale izrazite posledice, ko smo 
vsebnost seruma znižali pod 2 %. 
Učinki zniževanja serumske koncentracije na celično morfologijo so se pokazali pri 
spremembi celične oblike iz običajnih vretenastih celic, podobnih fibroblastom, v veliko 
večje celice z veliko variabilnostjo v obliki in strukturi. Opazili smo razpotegnjene celice z 
izrazito kontrastnimi intracelularnimi strukturami, ki so rasle v skupkih in ne v 
enakomerno razporejeni enoslojni kulturi, ki je značilna za hMSC v normalnih pogojih. 
Spremembo oblike smo zaznali, ko smo celice prenesli v gojišča s 3 % HS (Hektor in 
TurboDoma) in z 1 % HS (SCM-1). Pri celicah, ki smo jih gojili v gojišču TurboDoma, 
smo pri 3 % HS zaznali tudi celice s podvojenimi jedri, ki pa niso zaključile delitve. 
Populacijske podvojitvene nivoje (PDL) smo izračunali iz števila celic, ki smo jih pridobili 
s štetjem celic s pomočjo hemocitometra. Štetje smo opravili pred nacepljanjem v sveže 
gojišče. Število celic je bilo potrebno tudi za določitev primerne redčitve celic za naslednjo 
pasažo. Ker smo celice za štetje obarvali z barvilom Tripansko modrilo, smo lahko poleg 
števila celic izračunali tudi viabilnost. Iz krivulj PDL smo lahko razbrali, da so celice, ki so 
bile gojene v gojiščih Hektor in TurboDoma, večino podvojitev opravile pred prenosom v 
sveže gojišče s 5 % HS. V prvotnih korakih zniževanja seruma so hMSC ostale viabilne, a 
so predvsem rastle v velikosti, niso pa se delile. Celice, ki so bile gojene v gojišču SCM-1, 
pa so se podvojevale, dokler je bila vsebnost seruma vsaj 2%. Pri nižjih koncentracijah tudi 
to gojišče ni zagotavljalo pogojev za normalno proliferacijo. Celice so začele odmirati pri 
koncentracijah seruma, nižjih od 1 %. Med 3 pristopi zniževanja serumske koncentracije 
smo najboljše rezultate pridobili pri počasnem in prilagojenem zniževanju, medtem ko se 
je pristop hitrega zniževanja izkazal za neprimernega. Pri tem pristopu se tudi celice, 
gojene v gojišču SCM-1, niso podvojevale, ko smo pričeli z zniževanjem seruma, kar 
očitno kaže na to, da je zniževanje potekalo prehitro in hMSC niso imele dovolj časa za 
prilagoditev. Kljub temu da so celice v gojišču SCM-1 izkazovale celično podvojevanje 
tudi pri nižjih koncentracijah seruma, pa so podvojevalni časi (DT) hitro postali veliko 
daljši od kontrolnih celic, ki so bile stalno gojene v kontrolnih pogojih (α-MEM + 10 % 
HS). Kontrolne celice so edine izkazovale dokaj konstantno proliferacijo preko daljšega 
časovnega obdobja (do pribl. 20 pasaže).  
Iz obarvanj s Tripanskim modrilom smo izračunali povprečne viabilnosti celic v različnih 
gojiščih, ki so bile podvržene različnim pristopom zmanjševanja serumske koncentracije. 
Povprečne viabilnosti so bile izračunane iz posameznih vrednosti, ki smo jih pridobili 
preko celotnega obdobja v kulturi. Tudi na tem področju so celice, ki so bile vključene v 
postopke zniževanja seruma, izražale nižje povprečne viabilnosti, ki so bile posledica 
izrazito nižjih viabilnosti pri pasažah z nižjo vsebnostjo seruma. V vseh treh postopkih 
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zniževanja so najnižje povprečne viabilnosti dosegale celice, gojene v gojiščih Hektor in 
TurboDoma. Te povprečne viabilnosti so bile pridobljene tudi preko najmanjšega števila 
pasaž, saj so celice začele odmirati že pri razmeroma visokih koncentracijah seruma (3 % 
HS). Prav tako pa smo pri celicah, ki so bile gojene v prej omenjenih gojiščih, zaznali tudi 
največjo variabilnosti v viabilnosti od pasaže do pasaže (50-90 % za Hektor; 35-90 % za 
TurboDoma). V nasprotju s hMSC, ki so bile namnoževane v gojiščih Hektor in 
TurboDoma, smo pri celicah v gojišču SCM-1 pridobili povprečne viabilnosti, ki so bile 
primerljive s kontrolnimi celicami. Pri postopku hitrega zniževanja je bila povprečna 
viabilnost celic v gojišču SCM-1 celo višja od kontrolnih celic, vendar lahko to razliko 
pripišemo problematiki previsoke konfluence kultur. Ko so celice dosegle 100% 
konfluenco, je bilo nemogoče ustvariti enotno suspenzijo brez velikih skupkov celic. Zato 
smo morali celične suspenzije filtrirati, kar je znižalo realno število namnoženih celic in 
znižalo viabilnost.  
Poleg klasičnega testiranja viabilnosti s pomočjo obarvanja s Tripanskim modrilom smo 
izvedli tudi MTT viabilnostni test. MTT je fotometrična metoda, ki nam omogoča 
določanje metabolne aktivnosti in s tem viabilnosti celic. V mitohondrijih se vodotopno 
rumeno barvilo MTT (3-(4,5-dimetiltiazol-2-il)-2,5-difeniltetrazolijev bromid) s strani 
NADH reducira v vijolično obarvan formazan. Količina formazana odraža metabolno 
aktivnost celic in s tem viabilnost. Za fotometrično detekcijo v vodi netopnega formazana 
moramo celice lizirati in kristale formazana raztopiti s SDS, razredčenim v HCl. Rezultati 
MTT proliferacijskih nivojev so se ujemali s podatki, ki smo jih pridobili s pomočjo ostalih 
analitskih metod. Edino odstopanje v vrednostih smo dobili pri proliferacijskih nivojih 
celic, ki so bile gojene v kemijsko definiranih gojiščih z 10 % HS. Proliferacijski nivoji so 
izrazito presegali povprečni proliferacijski nivo kontrolnih celic. Z zniževanjem serumske 
koncentracije pa so se proliferacijski nivoji po pričakovanjih znižali. Celice, ki so bile 
gojene v gojiščih Hektor in TurboDoma, so imele pri 5 % HS še vedno podoben ali malce 
nižji proliferacijski nivo kot celice v kontrolnem gojišču, pri nižjih koncentracijah seruma 
pa smo metabolno aktivnost zaznali le še v izrazito manjših vrednostih. Pri celicah, ki so 
bile gojene v gojišču SCM-1 je bil proliferacijski nivo tudi pri 3 % HS še vedno primerljiv 
s povprečnim nivojem kontrolnih celic. Pri prilagojenem zniževanju je bil proliferacijski 
nivo dokaj visok tudi pri 1 % HS, a je še vedno predstavljal le 65 % povprečnega 
proliferacijskega nivoja kontrolnih celic, medtem ko je pri 0.5 % HS nivo padel že na slabo 
tretjino povprečnega proliferacijskega nivoja kontrolnih celic. 
Poleg že omenjenih analiz smo tekom našega eksperimenta izvedli tudi β-galaktozidazni 
test senescence. Test zaznava β-galaktozidazno aktivnost pri pH vrednosti 6, ki je značilna 
lastnost celic, ki zapadejo v senescenco, ne zaznamo pa je pri nesenescentnih, mirujočih ali 
imortaliziranih celicah. Omejena zmožnost podvojevanja je ena od osnovnih značilnosti 
normalnih celic, ki sčasoma vodi v senescentno stanje. Senescenca je mirujoče stanje, v 
katerem celice ostanejo viabilne, a se ne delijo. Ko celice zapadejo v senescenco, postanejo 
za raziskovalne namene hMSC in terapevtsko uporabo neuporabne. Zato smo na 
kontrolnih celicah pri različnih pasažah (4, 24 in 26) opravili test senescence, da smo 
preverili, če po prenosu v brezserumske pogoje naše hMSC teoretično še spadajo med 
nesenescentne celice. Pri celicah iz 26. pasaže smo zaznali močno modro obarvanje, kar 
pomeni, da so že zapadle v senescenco. Pri celicah iz 24 pasaže smo zaznali zmerno 
obarvanje, medtem ko pa so celice iz 4 pasaže pričakovano ostale večinoma neobarvane. Iz 
testa senescence lahko razberemo, da celice zapadejo v senescenco okrog 24 pasaže. 
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Teoretično bi lahko torej po končanju prenosa v brezserumsko gojišče naše hMSc v kulturi 
pred pojavom senescence namnoževali še najdaljnih 6-14 pasaž. Število nadaljnih pasaž je 
odvisno od pristopa zniževanja serumske koncentracije (6 za počasno zniževanje, 14 za 
hitro). 
Rezultati vseh opravljenih testov kažejo na to, da nobeno izmed naših 3 kemijsko 
definiranih gojišč ne more podpirati gojenja hMSC brez dodatka seruma, ko so celice ob 
izolaciji in zamrzovanju izpostavljene gojiščem, ki vsebuje serum. Številne študije 
povezujejo slabe eksperimentalne rezultate ravno s tem, da so celice pred prilagajanjem na 
brezserumsko gojenje izpostavljene gojiščem s serumom. Obstaja namreč možnost, da se 
serumski kontaminanti prenašajo preko pasaž tudi ko celice prenesemo v brezserumske 
pogoje. Visoke proliferacijske nivoje celic, ki smo jih gojili v kemijsko definiranih gojiščih 
pri dodatku 10 % HS, lahko razložimo z visoko hranilno vrednostjo kemijskih gojišč. 
Gojišče Hektor je bilo razvito za gojenje številnih celičnih linij ledvičnih celic, medtem ko 
se gojišče TurboDoma uporablja za produkcijo monoklonskih protiteles s hibridomskimi 
celicami. Kljub dobrim proliferacijskim nivojem pri gojenju z 10 % HS, pa se z 
zniževanjem serumske koncentracje znižajo tudi proliferacijski nivoji vseh celic, ki so 
gojene v kemijsko definiranih gojiščih Hektor, TurboDoma in SCM-1. Prav tako so se 
znižali populacijski podvojevalni nivoji in viabilnost, pojavile pa so se tudi izrazite 
morfološke spremembe. Spremembe in negativne posledice lahko pripišemo različnim 
vzrokom, kot so: 
• Izpostavitev mehanskemu stresu med nacepljanjem. 
• Prehitro zniževanje serumske koncentracije. 
• Neprimeren pristop zniževanja. 
• Uporaba seruma v gojiščih za izolacijo in zamrzovanje celic. 
• Neprimerna raztopina za odcepitev celic od gojitvene površine. 
• Nizka viabilnost celic po odmrzovanju zaradi dolgega obdobja zamrznitve. 
• Formulacija gojišč, ki sama od sebe ne podpira gojenja hMSC brez vsebnosti 
seruma. 
V magistrskem delu smo zastavili številne iztočnice za nadaljnje raziskovanje kemijsko 
definiranih gojišč in njihove uporabe za gojenje hMSC v pogojih brez vsebnosti seruma. 
Čeprav nam ni uspelo prilagoditi hMSC na brezserumske pogoje v nobenem izmed 3 
proučevanih gojišč, pa se je gojišče SCM-1 izkazalo kot potencialni kandidat za nadaljnjo 
obravnavo. Obstaja možnost, da bi s primernim pristopom zniževanja serumske 
koncentracije, primerno prilagoditvijo formulacije ali z dodatkom določenih rastnih 
dejavnikov (npr. bFGF), gojišče uspešno omogočalo proliferacijo hMSC brez prisotnosti 
človeškega ali živalskega seruma. Med potencialne prihodnje pristope bi tu lahko umestili 
tudi neposredno izolacijo hMSC v brezserumska gojišča. Čeprav se zdi pristop sprva 
nelogičen, saj bi pričakovali, da nemuden prenos v gojitvene pogoje brez seruma 
predstavlja prevelik stres za hMSC, pa določene raziskovalne skupine (Jung in sod., 2012)  
prav ta pristop predpostavljajo kot najbolj primeren ter najbolj učinkovit. Z izločitvijo 
dolgih prilagoditvenih postopkov iz našega poskusa, bi pridobili tudi številne zgodnje 
pasaže, ki jih v nasprotnem primeru porabimo za samo adaptacijo. Z neposrednim 
prenosom bi lahko torej hMSC uporabljali od samega začetka, ko so te še mlade in 
genetsko stabilnejše. S tem bi se povečala uporabnost in vrednost izoliranih celic, zaradi 
popolne izločitve seruma pa bi tudi odstranili kakršen koli dvom o morebitnih 
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kontaminacijah, ki bi se nam lahko pripetile zaradi uporabe seruma v izolacijskem in 
zamrzovalnem koraku. Poleg spremembe pristopa bi lahko v prihodnosti na temeljih 
rezultatov magistrskega dela opravili številne dodatne analitske metode, ki jih zaradi 
izrazite delovne intenzitete poskusa, v času našega poskusa nismo uspeli. S pomočjo 
pretočne citometrije bi lahko opravili analize izražanja površinskih antigenov na hMSC in 
izvedli citogenetske analize s kariotipizacijo in primerjalno genomsko hibridizacijo. 
Seveda so to le ene izmed možnih analiz, ki bi nam priskrbele še dodatne informacije o 
učinkih zniževanja serumske koncentracije na hMSC. Nekatere izmed teh metod smo 
želeli opraviti že tekom našega poskusa, a smo se na koncu osredotočili na analizo 
različnih pristopov zniževanja serumske koncentracije skozi metabolno aktivnost, celično 
morfologijo, hitrost rasti in viabilnost, s čimer smo postavili temelje za prihodnje 
raziskave.  
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